<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6252316</article-id><article-id pub-id-type="doi">10.3389/fimmu.2018.02364</article-id><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Emerging Role of Immunosuppression in Diseases Induced by Micro- and Nano-Particles: Time to Revisit the Exclusive Inflammatory Scenario</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Huaux</surname><given-names>Fran&#x000e7;ois</given-names></name><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/558395/overview"/></contrib></contrib-group><aff><institution>Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Experimentale et Clinique, Universit&#x000e9; catholique de Louvain</institution>, <addr-line>Brussels</addr-line>, <country>Belgium</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Martin Herrmann, Universit&#x000e4;tsklinikum Erlangen, Germany</p></fn><fn fn-type="edited-by"><p>Reviewed by: Ahmed El-Fiqi, Dankook University, South Korea; Arnaud Millet, INSERM Institut pour l'Avanc&#x000e9;e des Biosciences (IAB), France</p></fn><corresp id="c001">*Correspondence: Fran&#x000e7;ois Huaux <email>francois.huaux@uclouvain.be</email></corresp><fn fn-type="other" id="fn001"><p>This article was submitted to Inflammation, a section of the journal Frontiers in Immunology</p></fn></author-notes><pub-date pub-type="epub"><day>19</day><month>11</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>9</volume><elocation-id>2364</elocation-id><history><date date-type="received"><day>04</day><month>5</month><year>2018</year></date><date date-type="accepted"><day>24</day><month>9</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 Huaux.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Huaux</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Fibrosis, cancer, and autoimmunity developing upon particle exposure have been exclusively linked with uncontrolled inflammatory processes. The critical role of inflammation is now challenged by several contradictory observations indicating that the emergence of these chronic disorders may result from non-inflammatory events. A growing number of studies reveals that micro- and nano-particles can cause exaggerated and persistent immunosuppression characterized by the release of potent anti-inflammatory cytokines (IL-10 and TGF-&#x003b2;), and the recruitment of major regulatory immune cells (M2 macrophages, T and B regs, and MDSC). This persistent immunosuppressive environment is initially established to limit early inflammation but contributes later to fibrosis, cancer, and infection. Immunosuppression promotes fibroblast proliferation and matrix element synthesis and subverts innate and adaptive immune surveillance against tumor cells and microorganisms. This review details the contribution of immunosuppressive cells and their derived immunoregulatory mediators and delineates the mutual role of inflammatory vs. immunosuppressive mechanisms in the pathogenesis of chronic diseases induced by particles. The consideration of these new results explains how particle-related diseases can develop independently of chronic inflammation, enriches current bioassays predicting particle toxicity and suggests new clinical strategies for treating patients affected by particle-associated diseases.</p></abstract><kwd-group><kwd>immunosuppression</kwd><kwd>inflammation</kwd><kwd>TGF-&#x003b2;</kwd><kwd>IL-10</kwd><kwd>immunosuppressive lymphocytes</kwd><kwd>immunosuppressive myeloid cells</kwd></kwd-group><counts><fig-count count="3"/><table-count count="1"/><equation-count count="0"/><ref-count count="142"/><page-count count="11"/><word-count count="9602"/></counts></article-meta></front><body><sec id="s1"><title>Micro- and nano-particles in the twenty-first century</title><p>The toxicity of inhaled particles and the subsequent development of health diseases including fibrosis, cancer and autoimmunity are recognized since several centuries (<xref rid="B1" ref-type="bibr">1</xref>). Unfortunately, the available scientific knowledge is not yet adequate for monitoring particle exposure-related health problems, delivering treatment to affected patients, and devising appropriate early recognition of reactive particles and individuals at risk (<xref rid="B2" ref-type="bibr">2</xref>&#x02013;<xref rid="B4" ref-type="bibr">4</xref>). For example, although silicosis has been known for decades, exposure to dusts containing free crystalline silica remains uncontrolled in countless workplaces throughout the world and clinical cases of chronic diseases caused by inhaled particles are still frequent (<xref rid="B5" ref-type="bibr">5</xref>&#x02013;<xref rid="B7" ref-type="bibr">7</xref>). Despite active research, the highly lethal disorders caused by silica inhalation continue to pose major clinical challenges because there are refractory to current therapeutic strategies (<xref rid="B8" ref-type="bibr">8</xref>). In addition, clinical detection of silica-associated lung diseases is currently dependent on radiological and lung function tests, which are both late manifestations of diseases (<xref rid="B8" ref-type="bibr">8</xref>). Therefore, effective therapeutic regimen and early disease detection have yet to be identified and developed. This problematic is not limited to naturally occurring mineral dusts. The recent ability to manipulate the structure and the morphology of particles, allowing the production of tailor-made dusts with specific size, form and function opens very attractive avenues in nanobiotechnologies and industries. However, for the successful application of these new materials now largely designed and produced worldwide, it is becoming evident that the biological fate and potential toxicity of these particles have to be actively determined (<xref rid="B9" ref-type="bibr">9</xref>). Hence, it is becoming vital to understand how complex pathologies (fibrosis, cancer, and autoimmune disorders) are induced by inhaled particles in order to reduce their impacts on human health.</p></sec><sec id="s2"><title>Inflammation as the driving force</title><p>The fundamental concept, usually put forward to explain the pathogenesis of particle-induced fibrosis, cancer, and autoimmune diseases, is relatively simple. An unresolved and chronic inflammatory process, characterized by marked inflammatory cell accumulation and sustained release of inflammatory molecules, damages tissues, orchestrates accumulation of mesenchymal cells and their matrix protein products, transforms normal cells to tumor cells or activates adaptive immune responses to self-antigens (<xref rid="B10" ref-type="bibr">10</xref>).</p><p>A precise cascade of cellular and molecular inflammatory events has been proposed from an extensive and growing number of data in human and animal exposed to particles (Figure <xref ref-type="fig" rid="F1">1</xref>). First, sentinel (alveolar and interstitial macrophages) and resident cells (epithelial cells and fibroblasts) actively recognize particles through sophisticated innate immune platforms (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>). These activated cells release various inflammatory mediators such as cytokines, chemokines, eicosanoids, and free radicals (<xref rid="B13" ref-type="bibr">13</xref>&#x02013;<xref rid="B16" ref-type="bibr">16</xref>). These mediators induce a marked and persistent recruitment of inflammatory myeloid or lymphoid cells (inflammatory M1 macrophages; neutrophils, monocytes, and effector T lymphocytes) that results in tissue damages. Persistent inflammation-induced injury is subsequently followed by an exaggerated reparative phase in which polypeptide growth factors produced by inflammatory cells stimulate non-controlled fibroblast recruitment, proliferation, and matrix protein production (<xref rid="B1" ref-type="bibr">1</xref>). Released reactive oxygen or nitrogen species (ROS and RNS) play a major role in the genotoxic activity of particles. Under inflammatory conditions, free radicals generated from the particle itself or inflammatory cells induce DNA damage in target cell populations and participate in the carcinogenic process (<xref rid="B17" ref-type="bibr">17</xref>). Again, tissue damage and inflammation associated to inhaled particles are the suspected pathological pathway that leads to immune abnormalities, adaptive immunity activation, tolerance breaking, antinuclear autoantibody production and finally systemic autoimmune diseases including lupus and arthritis (<xref rid="B10" ref-type="bibr">10</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Predominant unresolved inflammation contributes in the development of chronic diseases related to particle exposure. The pathological pathway classically described suggests that a predominant and persistent inflammatory process (in green) orchestrates fibrosis, cancer, and autoimmune diseases caused by particles (in yellow). Reactive particles induce an inflammatory cascade, which implies TNF-&#x003b1;, IL-1 &#x003b1;, and &#x003b2;, IFNs (IFN-&#x003b3; and &#x003b2;), IL-17, and free radicals (ROS and RNS) and precedes the influx of inflammatory macrophages (M1 M&#x003d5;), inflammatory myeloid cells (iMono, inflammatory monocytes; iNeut, inflammatory neutrophils), and effector T lymphocytes (T eff, comprising Th1, &#x003b3;&#x003b4; T cells, and Th17). When immunosuppressive activities are insufficient, these pro-inflammatory mediators and cells persist and result in to uncontrolled cycle of injury. Pro-inflammatory cytokines are also considered as potent polypeptide growth factors for mesenchymal cells and ultimately induce fibrosis. Sustained production of free radicals induces irreversible DNA damage and results in carcinogenesis. Constant tissue damage and inflammation activate adaptive immunity, autoantibody production and autoimmunity.</p></caption><graphic xlink:href="fimmu-09-02364-g0001"/></fig><p>A myriad of inflammatory mediators accompanying inflammation are linked to scar formation, cell transformation, and autoimmunity but only few of them are definitively identified as important in the pathological processes. Among those, the master pro-inflammatory cytokines TNF-&#x003b1;, IL-1 (mainly produced by M1 macrophages), type I and II IFN and IL-17 (from effector T lymphocytes as Th1, &#x003b3;&#x003b4; T cells, and Th17) are essential in the pathogenesis of particle-induced diseases (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B18" ref-type="bibr">18</xref>&#x02013;<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>). These inflammatory mediators are responsible of leukocyte influx in damaged tissues and orchestrate aggregation of mature phagocytic macrophages and granuloma formation (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>). In addition, they promote fibroblast activation and differentiation (<xref rid="B24" ref-type="bibr">24</xref>), epithelial or mesothelial cell transformation (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B25" ref-type="bibr">25</xref>) and immune responses to self-antigens (<xref rid="B26" ref-type="bibr">26</xref>&#x02013;<xref rid="B28" ref-type="bibr">28</xref>). Inflammatory cell accumulation, collagen deposition, or malignant mesothelioma in silica- or asbestos-treated mice was markedly decreased by suppressing genetically or pharmacologically these key inflammatory mediators (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B29" ref-type="bibr">29</xref>). Increased levels of TNF-&#x003b1;, IL-1, IFN-&#x003b3;, and IL-17 have been observed in human under conditions of developing silicosis, asbestosis or mesothelioma (<xref rid="B30" ref-type="bibr">30</xref>&#x02013;<xref rid="B33" ref-type="bibr">33</xref>). These findings convincingly indicate a causal relationship between excessive or maintained accumulation of pro-inflammatory cells and cytokines and the establishment of particle-induced chronic diseases.</p></sec><sec id="s3"><title>Recent clinical and experimental findings that challenge the inflammatory dogma</title><p>Current treatment modalities for treating patients developing particle-related diseases have been based on the assumption that these disorders are exclusively related to chronic inflammation diseases. However, it is becoming evident that most available anti-inflammatory drugs (<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B35" ref-type="bibr">35</xref>) or cytokine inhibitor therapy (<xref rid="B36" ref-type="bibr">36</xref>) are not effective for particle-exposed patients. Human validation studies have also failed to confirm the use of inflammatory mediators as biomarkers for univocally detecting the health effects of particles (<xref rid="B37" ref-type="bibr">37</xref>).</p><p>Besides the strong evidence of a major role of inflammation in particle-treated animals, several experimental studies did not find an evident association between inflammatory responses and experimental diseases and, thus, have also challenged this inflammatory dogma. Several studies, conducted in mice, reported that exacerbated lung inflammation is not always accompanied by a subsequent increase of fibrosis after silica or carbon nanotubes (CNT) treatment (<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>). Inversely, limited inflammation can be associated to robust silica-induced long-term lung responses (<xref rid="B40" ref-type="bibr">40</xref>). More precisely, it has been found that a progressive neutrophilic inflammatory process and a sustained release of pro-inflammatory cytokines did not accompany instillation of silica or CNT in mice. In this case, a mild and non-progressive pulmonary inflammation and a transient production of pro-inflammatory cytokines such TNF-&#x003b1; and IL-1&#x003b2; was instead observed (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B41" ref-type="bibr">41</xref>&#x02013;<xref rid="B43" ref-type="bibr">43</xref>). Additionally, these inflammatory components were dispensable for the development of particles-induced fibrogenesis since genetic deficiencies of these master pro-inflammatory cytokines did not completely limit lung fibrosis while they were efficient to abrogate inflammation and granuloma formation after silica or CNT (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B44" ref-type="bibr">44</xref>&#x02013;<xref rid="B46" ref-type="bibr">46</xref>). Other key pro-inflammatory cytokines such as type I interferons, IL-12, IL-17, and IL-22 were also dispensable in the development of silica-induced fibrosis (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B47" ref-type="bibr">47</xref>). The non-requirement of inflammation during experimental lung fibrosis was further supported by the fact that different treatments with anti-inflammatory molecules such as steroids, cox- or phosphodiesterase 5-inhibitors strongly reduced inflammation without modifying, however, collagen deposition (<xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B43" ref-type="bibr">43</xref>). The disconnection between inflammation and particle toxicity is not limited to fibrosis. In mice, co-exposure to silica and carcinogens from tobacco smoke resulted in rapid tumor growth in the lungs that is attenuated in the absence of leukotriene B4 axis. This mechanism is, however, independent of IL-1 activation, TNF-&#x003b1; production and chemokine release (<xref rid="B48" ref-type="bibr">48</xref>). In addition, early inflammatory reactions triggered by asbestos required NLRP3 inflammasome activation and IL-1&#x003b2; release, but this pathway was not critical in the chronic development of asbestos-induced mesothelioma (<xref rid="B49" ref-type="bibr">49</xref>). Recent investigations additionally showed that non-steroidal anti-inflammatory molecules do not reduce progression of asbestos-induced mesothelioma in animals (<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B50" ref-type="bibr">50</xref>).</p><p>Altogether, these results strongly suggest that other pathophysiological mechanisms unrelated to inflammation are operational after particle exposure. There are now emerging studies from the literature that explain why diseases achieved by particles are not systematically related to inflammation. This review covers existing evidence supporting that immunosuppression represents an alternative pathological pathway in the development of particle-induced disorders. The most relevant studies delineating the immunosuppressive properties of (nano)particles are depicted in the following sections and commented in Table <xref rid="T1" ref-type="table">1</xref>.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Historical progression of immunosuppression in particle toxicology literature: Summary of the most relevant studies supporting immunosuppressive properties of (nano) particles.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Authors</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Highlighted observations</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Particles</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Source</bold></th></tr></thead><tbody><tr style="border-bottom: thin solid #000000;"><td valign="top" align="left" rowspan="1" colspan="1">Huaux et al. (<xref rid="B51" ref-type="bibr">51</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">An experimental study revealing for the first time that lung responses to silica are unexpectedly characterized by the persistent expression of IL-10, a powerful anti-inflammatory cytokine.<break/>
<italic>IL-10 was additionally detected after CNT exposure in murine models. Patients developing silicosis or asbestosis exhibit elevated lung levels of IL-10</italic>.</td><td valign="top" align="left" rowspan="1" colspan="1">silica<break/><break/><break/><break/>
<italic>CNT</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><italic>Am J Respir Cell Mol Biol</italic></italic><break/> 18:51-9<break/>
<bold>1998</bold><break/>
<italic>references #</italic> (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B52" ref-type="bibr">52</xref>, <xref rid="B53" ref-type="bibr">53</xref>)</td></tr><tr style="border-bottom: thin solid #000000;"><td valign="top" align="left" rowspan="1" colspan="1">Ryan et al. (<xref rid="B54" ref-type="bibr">54</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">This original study describes the unanticipated anti-inflammatory effects of NP by negatively regulating allergic inflammation.<break/><break/>
<italic>This immunosuppressive activity was confirmed in several models of inflammation with various nanoparticles</italic>.</td><td valign="top" align="left" rowspan="1" colspan="1">fullerene NP<break/><break/>
<italic>Oxide and carbon NP</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><italic>J Immunol</italic></italic><break/> 179:665-72<break/>
<bold>2007</bold><break/>
<italic>references #</italic> (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B55" ref-type="bibr">55</xref>, <xref rid="B56" ref-type="bibr">56</xref>)</td></tr><tr style="border-bottom: thin solid #000000;"><td valign="top" align="left" rowspan="1" colspan="1">Mitchell et al. (<xref rid="B57" ref-type="bibr">57</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">In investigating how CNT suppress immune function, this paper was the first and perhaps the most convincing to propose that nanoparticles induce immunosuppression orchestrated by IL-10 and TGF-&#x003b2;.</td><td valign="top" align="left" rowspan="1" colspan="1">CNT</td><td valign="top" align="left" rowspan="1" colspan="1"><italic><italic>Nat Nanotechnol</italic></italic><break/> 4:451-6<break/>
<bold>2009</bold></td></tr><tr style="border-bottom: thin solid #000000;"><td valign="top" align="left" rowspan="1" colspan="1">Lo Re et al. (<xref rid="B58" ref-type="bibr">58</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">This paper was the first indicating that silica-induced lung fibrosis results from TGF-&#x003b2;-producing regulatory T lymphocytes (T regs).<break/><break/>
<italic>NP also promote a selective expansion of T regs. The pathological role of T regs was confirmed in silicosis and mesothelioma</italic>.</td><td valign="top" align="left" rowspan="1" colspan="1">silica<break/><break/><break/>
<italic>polystyrene NP</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><italic>Am J Respier Crit Care Med</italic></italic><break/> 184:1270-81<break/>
<bold>2011</bold><break/>
<italic>references #</italic> (<xref rid="B59" ref-type="bibr">59</xref>&#x02013;<xref rid="B61" ref-type="bibr">61</xref>)</td></tr><tr style="border-bottom: thin solid #000000;"><td valign="top" align="left" rowspan="1" colspan="1">Shvedova et al. (<xref rid="B62" ref-type="bibr">62</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">This manuscript elegantly demonstrated that TGF-&#x003b2;-expressing MDSC (Myeloid Derived Suppressive Cells) are crucial for tumor development associated to CNT.<break/><break/>
<italic>MDSC are also implicated in silica-induced lung fibrosis and mesothelioma</italic>.</td><td valign="top" align="left" rowspan="1" colspan="1">CNT<break/><break/><break/>
<italic>silica</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><italic>Small</italic></italic><break/> 243:320-30<break/>
<bold>2013</bold><break/>
<italic>references #</italic> (<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B64" ref-type="bibr">64</xref>)</td></tr><tr style="border-bottom: thin solid #000000;"><td valign="top" align="left" rowspan="1" colspan="1">Murthy et al. (<xref rid="B53" ref-type="bibr">53</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">A comprehensive study showing that asbestos preferentially polarized M2 macrophages during asbestosis in animal and human.<break/><break/>
<italic>Other particles promoted accumulation of M2 macrophages</italic>.</td><td valign="top" align="left" rowspan="1" colspan="1">asbestos<break/><break/><break/>
<italic>silica and CNT</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><italic>FASEB</italic></italic><break/> 29:3527-36<break/>
<bold>2015</bold><break/>
<italic>reference #</italic> (<xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B66" ref-type="bibr">66</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Chen et al. (<xref rid="B37" ref-type="bibr">37</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">This paper indicated that silicosis and silica-induced lung responses (see related reference #101) are associated with immunosuppressive IL-10-producing B lymphocytes (B regs).</td><td valign="top" align="left" rowspan="1" colspan="1">silica</td><td valign="top" align="left" rowspan="1" colspan="1"><italic><italic>Front Immunol</italic></italic><break/> 8:110<break/>
<bold>2017</bold></td></tr></tbody></table><table-wrap-foot><p><italic>CNT, carbon nanotubes; NP, nanoparticles</italic>.</p></table-wrap-foot></table-wrap></sec><sec id="s4"><title>Involvement of the anti-inflammatory and immunosuppressive cytokines TGF-&#x003b2; and IL-10</title><p>Indubitably, TGF-&#x003b2; is associated with the development of responses to particles in human and animal. Elevated TGF-&#x003b2; expression has been observed in patients with asbestosis or silicosis (<xref rid="B67" ref-type="bibr">67</xref>&#x02013;<xref rid="B71" ref-type="bibr">71</xref>). In a variety of animal models, TGF-&#x003b2; activation has been demonstrated following exposure to silica, asbestos, or CNT (<xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B72" ref-type="bibr">72</xref>, <xref rid="B73" ref-type="bibr">73</xref>). After particles exposure, TGF-&#x003b2; contributes to fibroproliferative reorganization of organ tissue by orchestrating myofibroblast differentiation, collagen overproduction, and scar formation (<xref rid="B74" ref-type="bibr">74</xref>, <xref rid="B75" ref-type="bibr">75</xref>). Previous studies have demonstrated that treatment with TGF-&#x003b2; inhibitors decreased lung fibrosis in animals exposed to silica (<xref rid="B76" ref-type="bibr">76</xref>&#x02013;<xref rid="B78" ref-type="bibr">78</xref>). Additionally, TGF-&#x003b2; contributes to generate a favorable microenvironment for tumor growth and metastasis in mesothelioma, assigning this cytokine as dominant during the development of cancer induced by particles (<xref rid="B79" ref-type="bibr">79</xref>). It is noteworthy that the main function of TGF-&#x003b2; is immunosuppression since TGF-&#x003b2;1-deficient mice die from uncontrolled systemic inflammation and autoreactive T lymphocyte accumulation (<xref rid="B80" ref-type="bibr">80</xref>). The pivotal role of TGF-&#x003b2; argues for the development of other mechanisms than inflammation after particle exposure and supports that master immunosuppressive cytokines are also linked to particle-related diseases.</p><p>Because the anti-inflammatory cytokine IL-10 was effective in the regulation of inflammation, several authors have suggested that this cytokine could also be active in controlling inflammation in the early and late responses to mineral particles and thus plays a beneficial role based on the inflammatory paradigm (<xref rid="B81" ref-type="bibr">81</xref>&#x02013;<xref rid="B83" ref-type="bibr">83</xref>). However, several lines of evidence have demonstrated that IL-10 (as TGF-&#x003b2;) possesses deleterious and pro-fibrotic functions after particle exposure. First, lung expression of IL-10 was intimately associated to the development of particle-induced fibrosis and cancer and could explain the absence of chronic and progressive inflammation in human and mouse models (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B53" ref-type="bibr">53</xref>, <xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B84" ref-type="bibr">84</xref>&#x02013;<xref rid="B88" ref-type="bibr">88</xref>). Additional data supports that IL-10 participates in the extension of fibrosis since targeted overexpression of IL-10 in the murine airways caused, by itself, collagen deposition, accumulation of mesenchymal cells and airway remodeling with fibrosis (<xref rid="B89" ref-type="bibr">89</xref>, <xref rid="B90" ref-type="bibr">90</xref>). Subsequently, it has been demonstrated that IL-10 limits inflammatory response but promotes fibrotic reaction. Indeed, mice deficient for IL-10 developed exaggerated acute inflammation but limited lung fibrosis in response to silica (<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B91" ref-type="bibr">91</xref>). Conversely, overexpression of IL-10 in the lung, by using an adenovirus coding for this cytokine, limited the inflammatory process induced by silica, but increased the fibrotic response (<xref rid="B92" ref-type="bibr">92</xref>). It is now admitted that this potent immunosuppressive cytokine has direct effects on fibroblasts and matrix protein release (<xref rid="B93" ref-type="bibr">93</xref>). In addition, IL-10 induces the expression of pro-fibrotic mediators (i.e., TGF-&#x003b2;) by macrophages and limits the synthesis of anti-fibrotic mediators (i.e., prostaglandin E2) by epithelial cells (<xref rid="B91" ref-type="bibr">91</xref>). The deleterious effect of IL-10 is not limited to fibrosis development but is also implicated in the carcinogenic process resulting from particles. Recent results showed that asbestos exposure restricts effector T lymphocyte activation and impairs anti-tumor immunity through IL-10 release (<xref rid="B69" ref-type="bibr">69</xref>, <xref rid="B94" ref-type="bibr">94</xref>). IL-10-expressing macrophages increased mesothelioma cell proliferation and resistance to treatment (<xref rid="B85" ref-type="bibr">85</xref>, <xref rid="B95" ref-type="bibr">95</xref>). Collectively, these data additionally challenge the concept that only pro-inflammatory mediators and inflammation lead to fibrosis and cancer and conclusively demonstrate a key role of persistent immunosuppressive mediators in the development of particle-related disorders in the absence of inflammation (Figure <xref ref-type="fig" rid="F2">2</xref>).</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Pathological functions of persistent immunosuppressive cells and mediators during long-term responses to particles. Unresolved Immunosuppression (in blue) represents an alternative event during the responses to particles. According to this new pathological pathway, fibrogenesis, and carcinogenesis are governed by a persistent accumulation of immunosuppressive myeloid (M2 and MDSC) and lymphoid (T and B regs) cells and a sustained production of their related cytokines (IL-10 and TGF-&#x003b2;). These immunoregulatory components limit both the recruitment of inflammatory cells and the activity of pro-inflammatory mediators (in green). The high amount of immunosuppressive cytokines produced can, in addition to their anti-inflammatory action, also act as profibrotic mediators, conceivably by stimulating mesenchymal cells to overproduce collagenase inhibitors and ultimately matrix elements under non-inflammatory conditions. The persistence of immunosuppressive cells and mediators is also incriminated in carcinogenesis and infection by preventing host immune responses directed against transformed cells and microorganisms.</p></caption><graphic xlink:href="fimmu-09-02364-g0002"/></fig></sec><sec id="s5"><title>Contribution of regulatory T and B lymphocytes in response to particles</title><p>Based on the immunosuppressive profile of silica-treated mice, the role of regulatory T lymphocytes (T regs) in the development of lung responses to particles was investigated. This specialized thymus-derived sub-population of Th lymphocytes acts to suppress immune responses, thereby maintaining homeostasis and self-tolerance. They mediate immunosuppression by producing the immunoregulatory cytokines IL-10 and TGF-&#x003b2; (<xref rid="B96" ref-type="bibr">96</xref>). Recent results indicated that T regs are progressively and specifically accumulated in lung tissue of mice treated with silica where they promote pulmonary immunosuppression and fibrosis (<xref rid="B58" ref-type="bibr">58</xref>, <xref rid="B60" ref-type="bibr">60</xref>) (Figure <xref ref-type="fig" rid="F2">2</xref>). This hallmark of immunological tolerance and immunosuppressive environment was observed with other particles, detected locally and systemically, and induced by the Wnt/B-catenin pathway (<xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B97" ref-type="bibr">97</xref>, <xref rid="B98" ref-type="bibr">98</xref>). Lung T regs directly stimulated fibroblast proliferation and collagen deposition after transfer in non-treated mice (<xref rid="B58" ref-type="bibr">58</xref>). The direct profibrotic effects of T regs were reduced by inhibiting the PDGF-B/TGF-&#x003b2; signaling pathway, demonstrating that T regs increase tissue fibroblast numbers, and consequently, amplify collagen deposition. <italic>In vitro</italic> and <italic>in vivo</italic> studies additionally showed that mesotheliomagenic fibers such as asbestos directly enhance the immunosuppressive function of T regs and their capacity to release TGF-&#x003b2; and IL-10 (<xref rid="B61" ref-type="bibr">61</xref>, <xref rid="B94" ref-type="bibr">94</xref>). In addition, the marked presence of T regs have been detected during lung carcinogenesis after silica or asbestos exposure (<xref rid="B99" ref-type="bibr">99</xref>, <xref rid="B100" ref-type="bibr">100</xref>). From these last studies, it has been concluded that the effect of particles on T regs accumulation and function induces a maintained tolerant microenvironment counteracting anti-tumor host innate and adaptive immunity and favoring tumoral cell evasion and the occurrence of particle-induced tumors.</p><p>More recently, Chen and colleagues have identified an additional immunosuppressive subpopulation of B lymphocytes recruited in response to silica in human and animal (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B101" ref-type="bibr">101</xref>) (Figure <xref ref-type="fig" rid="F2">2</xref>). Regulatory B-lymphocytes (B regs) are immunosuppressive cells releasing IL-10 and TGF-&#x003b2; that support immunological tolerance and suppress immunopathology by limiting the expansion of inflammatory T cells. B regs are defined as the immunosuppressive counterpart of antibody-producing B2 lymphocytes (or conventional B cells) (<xref rid="B102" ref-type="bibr">102</xref>). The regulatory B-cell subpopulation has been reported to be recruited to the tumor aggregates and thereby promotes carcinogenesis by attenuating anti-tumor immune responses (<xref rid="B103" ref-type="bibr">103</xref>). Their pro-fibrotic functions have been attributed to their capacity to release IL-10 in silica-treated mice (<xref rid="B101" ref-type="bibr">101</xref>). As observed in IL-10-deficient mice, reduction of fibrosis in B reg-depleted mice was associated with an increased neutrophilic inflammation (<xref rid="B101" ref-type="bibr">101</xref>). Interestingly, IL-10-producing B regs convert T eff into T regs thus increasing immunological tolerance after particle exposure (<xref rid="B104" ref-type="bibr">104</xref>). The observation that immunosuppressive T and B-lymphocytes persistently populate damaged tissue strongly suggests that these cells are crucial immune components explaining the development of fibrotic and carcinogenic responses to particles in absence of substantial inflammation.</p></sec><sec id="s6"><title>Critical roles of immunosuppressive myeloid cells</title><p>Infiltrated macrophages in cancer or asthma acquire a particular phenotype called M2, which provides an immunosuppressive microenvironment for tumor growth and allergic tolerance (<xref rid="B105" ref-type="bibr">105</xref>, <xref rid="B106" ref-type="bibr">106</xref>). Recent studies also revealed a preferential engagement of immunosuppressive M2 macrophages after inhalation of particles (Figure <xref ref-type="fig" rid="F2">2</xref>). There is an increased predominance of M2-polarized macrophages in patients developing asbestosis (<xref rid="B53" ref-type="bibr">53</xref>). In animal, M2-related mediators such as Arginase 1, crystallizable protein YM-1 or IL-10 were all increased in response to reactive particles such as silica, ultrafine amorphous silica and CNT, appointing M2-polarized macrophages as pivotal (<xref rid="B53" ref-type="bibr">53</xref>, <xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B66" ref-type="bibr">66</xref>, <xref rid="B107" ref-type="bibr">107</xref>&#x02013;<xref rid="B109" ref-type="bibr">109</xref>). Authors have recently incriminated oxidized phospholipids, IL-4 or IL-13 in the polarization of M2 macrophages that display enhanced production of TGF-&#x003b2;. Evidence also showed that this last cytokine explains the deleterious activities of M2 macrophages after particle treatment (<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B53" ref-type="bibr">53</xref>, <xref rid="B110" ref-type="bibr">110</xref>&#x02013;<xref rid="B112" ref-type="bibr">112</xref>). These results therefore argue that the continuous accumulation of M2 macrophages and their products, initially for counteracting the effects of inflammatory M1 macrophages, participates in the establishment of the fibrogenic and mesotheliomagenic lesions generated by particles.</p><p>Myeloid-derived suppressor cells (MDSC) represent a heterogeneous population of immature neutrophilic and monocytic myeloid cells that displays potent immunosuppressive activities and inhibits immune effector cell functions in diverse chronic pathologies such as cancer (<xref rid="B113" ref-type="bibr">113</xref>). The accumulation of immature and immunosuppressive myeloid cells is also a central event during dust-induced fibrosis and cancer with predominant immunosuppression (Figure <xref ref-type="fig" rid="F2">2</xref>). Indeed, recent investigations have elegantly demonstrated that CNT or asbestos exposure induces a robust accumulation of MDSC that actively release TGF-&#x003b2; and promote cancer progression in mice (<xref rid="B62" ref-type="bibr">62</xref>, <xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B114" ref-type="bibr">114</xref>). Fibrotic responses to silica also comprise an accumulation of monocytic MDSC that possess the intrinsic capacity to promote release of the collagenase inhibitor TIMP-1 by fibroblasts. The subsequent elaboration of a non-degrading matrix environment was attributed to monocytic MDSC-derived TGF-&#x003b2; (<xref rid="B63" ref-type="bibr">63</xref>). These observations newly indicate that immunoregulatory M2 macrophages and MDSC, along with T and B regs, are implicated in fibrogenesis and carcinogenesis, especially when these cells are continuously accumulated and when inflammatory activity is limited (Figure <xref ref-type="fig" rid="F2">2</xref>).</p></sec><sec id="s7"><title>Nanoparticles induce immunosuppression</title><p>The emerging concept that particles orchestrate the establishment of immunosuppressive responses is consolidated by several studies exploring the impact of nanoparticles on the immune system. As mentioned above for micrometric particles, the major concern in the field of nanotoxicology is historically related toward the capacity of nanoparticles to induce inflammation and immunostimulation (<xref rid="B115" ref-type="bibr">115</xref>). Nevertheless, this exclusive view has been revisited and recent attention has been given to anti-inflammatory and immunosuppressive properties of these particles (<xref rid="B55" ref-type="bibr">55</xref>). There is, indeed, a growing body of evidence showing that nanoparticles also display strong immunosuppressive effects (<xref rid="B56" ref-type="bibr">56</xref>). In 2007, Ryan and colleagues were the first to report that fullerene nanoparticles prevented mast-cell related diseases such as asthma, arthritis, and sclerosis (<xref rid="B54" ref-type="bibr">54</xref>). Other pioneer studies unexpectedly discovered that dendrimer nanoparticles improved disease scores in animal models of granulomatous, autoimmune, and edema diseases (<xref rid="B116" ref-type="bibr">116</xref>). Another example illustrating the immunosuppressive properties of nanoparticles is the study by Rajan (<xref rid="B117" ref-type="bibr">117</xref>). Liposomal nanoparticles possess the ability to elicit an immunosuppressive cell environment that subsequently suppress anti-tumor immunity and favor tumor progression.</p><p>The particles inducing immunosuppression mainly include metal (e.g., gold, silver, iron oxide, cerium oxide, and zinc oxide) and carbon (CNT, fullerenes) nanoparticles (<xref rid="B56" ref-type="bibr">56</xref>). The immunosuppressive effects of nanoparticles also depend on their physicochemical properties. For instance, small nanoparticles are more immunosuppressive than large particles (<xref rid="B116" ref-type="bibr">116</xref>, <xref rid="B118" ref-type="bibr">118</xref>). The exact physicochemical determinants accountable for nanoparticle-induced immunosuppressive activities remain, however, unclear and require additional investigations. There is also a crucial need to determine whether molecules enrobing particles (e.g., LPS) are important for the immunosuppressive activities of (nano)particles (<xref rid="B115" ref-type="bibr">115</xref>).</p><p>Interestingly, research in nanotoxicology elucidated different molecular mechanisms explaining how particles promote immunosuppression. These mechanisms involve direct interference of nanoparticles with TLR-, NF&#x003ba;B-, or STAT1-signaling pathways (<xref rid="B55" ref-type="bibr">55</xref>, <xref rid="B119" ref-type="bibr">119</xref>). Iron nanoparticles specifically alter IL-1&#x003b2; processing by preventing inflammasome assembly (<xref rid="B120" ref-type="bibr">120</xref>). A direct inhibitory interaction between gold nanoparticles and inflammatory cytokines have been also observed from the study of Sumbayev (<xref rid="B118" ref-type="bibr">118</xref>). Carbon and cerium nanomaterials exhibit potent free radical-scavenger properties and attenuate oxidant molecule production by particle-activated immune cells. These findings confer to these nanoparticles important antioxidant properties that suppress oxidative stress and inflammatory responses <italic>in vitro</italic> and <italic>in vivo</italic> (<xref rid="B119" ref-type="bibr">119</xref>, <xref rid="B121" ref-type="bibr">121</xref>, <xref rid="B122" ref-type="bibr">122</xref>).</p><p>Nanoparticles strongly and directly polarize the immune system and establish a preferentially immunosuppressive environment. CNT induce the expression of TGF-&#x003b2; and IL-10 (<xref rid="B57" ref-type="bibr">57</xref>) as observed for micrometric silica (see above). Nanoparticles also facilitate polarization of immunosuppressive T regs and anti-inflammatory Th2 lymphocytes (<xref rid="B98" ref-type="bibr">98</xref>, <xref rid="B123" ref-type="bibr">123</xref>, <xref rid="B124" ref-type="bibr">124</xref>). Mechanistic studies investigating the effects of nanoparticles on T-lymphocyte immunosuppressive lineage commitment revealed that nanoparticles (carbon, grapheme, and iron) directly interfere with autophagy, ROS production, NF&#x003ba;B-nuclear translocation or antigen processing by dendritic cells (<xref rid="B124" ref-type="bibr">124</xref>&#x02013;<xref rid="B126" ref-type="bibr">126</xref>). While nanoparticles mainly operated through DC and T cells, they additionally target macrophages and myeloid cells. Liposomes reduced inflammatory functions of macrophages and increased anti-inflammatory mediator expression in myeloid cells (<xref rid="B117" ref-type="bibr">117</xref>).</p><p>The exact adverse effects of nanoparticle-induced unresolved immunosuppression are not yet delineated but fibrosis development caused by CNT or cerium has been linked to the immunosuppressive cytokines TGF-&#x003b2; and IL-10 (<xref rid="B52" ref-type="bibr">52</xref>, <xref rid="B72" ref-type="bibr">72</xref>, <xref rid="B127" ref-type="bibr">127</xref>, <xref rid="B128" ref-type="bibr">128</xref>). Altered host resistance to infection and cancer represents another possible pathophysiological consequence of maintained immunosuppression. Administration of titanium oxide nanoparticles or liposomes inhibited lymphocyte- and macrophage-related immune responses and increased susceptibility to tumor growth (<xref rid="B117" ref-type="bibr">117</xref>, <xref rid="B129" ref-type="bibr">129</xref>). Augmented viral and bacterial infections have also been observed after exposure to carbon nanoparticles (<xref rid="B130" ref-type="bibr">130</xref>, <xref rid="B131" ref-type="bibr">131</xref>).</p></sec><sec id="s8"><title>Mutual roles of inflammation and immunosuppression in responses to particles</title><p>Taken together, the studies described above and documented in Table <xref rid="T1" ref-type="table">1</xref> support an additional and alternative pathological pathway, which is operative during tissue responses to particles. This new paradigm proposes that fibrogenesis, carcinogenesis, and infections can develop from persistent immunosuppressive developments induced by micro- or nano-particles under non-inflammatory conditions (Figure <xref ref-type="fig" rid="F3">3</xref>, below). Unresolved immunosuppression participates in the development of fibrosis by activating profibrotic factor release and inhibiting matrix degradation. The immunosuppressive milieu can also favor cancer and infection progression by facilitating tumor and microbial escape from immune surveillance.</p><fig id="F3" position="float"><label>Figure 3</label><caption><p>Mutual roles of inflammatory and immunosuppressive responses in particle-induced chronic diseases. The classical scenario explaining the emergence of autoimmune diseases, fibrosis, and cancer after dust exposure mainly relies on predominant and persistent inflammation (blue). Inflammatory responses directly promote fibroblast growth and uncontrolled matrix deposition, trigger genomic instability, and cell transformation, and support autoantibody and immune complex production. An additional paradigm is now offered and comprises predominant and unresolved immunosuppression in response to particles (red). This pathway relies upon a sustained accumulation of immunosuppressive components that include mediators implicated in fibroblast activation, tumor cell and microbe evasion. The exclusive or simultaneous presence of immunoregulatory and immunostimulatory mechanisms can explain the diversity of immune responses and pathologies existing in exposed human or animal.</p></caption><graphic xlink:href="fimmu-09-02364-g0003"/></fig><p>This new pathological avenue does not overshadow the relevance of the inflammatory scenario. Indeed, the compelling findings accumulated over the years indubitably support that uncontrolled fibroblast growth and genomic instability rely upon predominant inflammation, especially when immunosuppressive activity is lacking (Figure <xref ref-type="fig" rid="F3">3</xref>, above). The emergence of immune complex deposition and autoimmune disorders is additionally associated to persistent inflammation in animal or human exposed to particles. The fact that particle-related autoimmune diseases are not mechanistically covered by sustained immunosuppression indicates that inflammation remains a crucial event in response to particles. Importantly, the inflammatory process governs the early accumulation of immunosuppressive cells and mediators by activating several anti-inflammatory signaling pathways (e.g., IL-10) mediated predominantly by NF&#x003ba;B (<xref rid="B132" ref-type="bibr">132</xref>). This notion indicates that inflammation can predispose to a developing immunosuppressive environment and that inflammation and immunosuppression are functionally linked.</p><p>Altogether, these observations clearly argue for a more complicated mechanism in particle toxicology, wherein both types of immune responses (persistent inflammation and immunosuppression) could promote chronic diseases after particle inhalation. The mutual roles of inflammation and immunosuppression well explain the diversity of particle-induced immune polarization and pathologies (Figure <xref ref-type="fig" rid="F3">3</xref>). Interestingly, these apparently opposite processes are not systematically exclusive and may be, in contrast, concomitant. The view that uncontrolled immunoregulatory and immunostimulatory responses can co-exist is supported by recent human and animal studies showing mixed inflammatory and immunosuppressive elements (e.g., elevated levels of TNF-&#x003b1;, IL-1&#x003b2;, IL-10, and TGF-&#x003b2;) during fibrogenesis and carcinogenesis induced by particles (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B133" ref-type="bibr">133</xref>, <xref rid="B134" ref-type="bibr">134</xref>).</p></sec><sec id="s9"><title>Toxicological and clinical perspectives</title><p>It remains, however, to learn how to extrapolate and how to benefit from these observations in predictive toxicology and translational medicine. Current bioassays testing particle reactivity are exclusively based on the appreciation of inflammatory components and suffer from a lack of specificity (<xref rid="B135" ref-type="bibr">135</xref>, <xref rid="B136" ref-type="bibr">136</xref>). These tests could be enriched by considering the expression of immunoregulatory mediators or signatures. For instance, release of TGF-&#x003b2; and IL-10 and subsequent abrogation of IL-1 and TNF-&#x003b1; production by treated macrophages could be used to identify reactive particles as proposed by the team of Boraschi and colleagues (<xref rid="B137" ref-type="bibr">137</xref>). Furthermore, blockade of inflammasome machinery or antigen-presenting capacity of macrophages and DC could be considered as clear sign of immunosuppressive responses. Inhibition of inflammatory pathologies in animal models could also reflect ability of particles to trigger immunosuppression (<xref rid="B56" ref-type="bibr">56</xref>).</p><p>In recent years, the increase of anti-tumor responses obtained in clinic trials by blocking the immunosuppressive environment of tumors have revolutionized cancer treatment. Monoclonal antibody-based immunotherapies targeting TGF-&#x003b2; and IL-10 or T cell immune checkpoint receptors (PD-1 or CTLA4) are now available and confer long-term benefit for patients (<xref rid="B138" ref-type="bibr">138</xref>&#x02013;<xref rid="B140" ref-type="bibr">140</xref>). Additional experimental and clinical studies are necessary to determine whether this therapeutic option inhibiting immunosuppressive responses is also promising for the treatment of patients affected by particle-associated disorders.</p><p>The existence of at least two different pathogenic routes may explain why existing therapies are controversial and disappointing with a strong differential effect in specific subgroups of patients (<xref rid="B141" ref-type="bibr">141</xref>, <xref rid="B142" ref-type="bibr">142</xref>). The opportunity to distinguish the prevailing immune response or profile (inflammation and immunosuppression) existing in patients should also help the clinician to categorize patients, assess disease progression and select the most appropriate therapy to inhibit key effector cells and mediators of inflammation (steroids) and/or immunosuppression (immunotherapy). This possibility has been already observed in available animal models. Silica-induced lung fibrosis in rats (associated with chronic inflammation) can be reverted by anti-inflammatory treatment while in mice (developing preferentially unresolved immunosuppressive responses), silicosis is resistant to anti-inflammatory therapy but prevented by T regs neutralization (<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B60" ref-type="bibr">60</xref>). The enthusiasm for the discovery of novel drug targets to treat particle-related diseases should be tempered as inflammation and immunosuppression are extremely imbricated with each other, leading to the fact that inhibition of one response may be compensated by the extension of the other (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B58" ref-type="bibr">58</xref>).</p></sec><sec id="s10"><title>Author contributions</title><p>The author confirms being the sole contributor of this work and has approved it for publication.</p><sec><title>Conflict of interest statement</title><p>The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was funded by the Actions de Recherche Concert&#x000e9;es, F&#x000e9;d&#x000e9;ration Wallonie-Bruxelles (ARC 09/14-021 and 14/19-056), the Fondation Contre le Cancer (2012-219, 2014-148, and 150), the Fonds de la Recherche Scientifique (FNRS; Projects PDR T.0119.13 and CDR J0049.16). FH is a Senior Research Associate with the FNRS, Belgium.</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sayan</surname><given-names>M</given-names></name><name><surname>Mossman</surname><given-names>BT</given-names></name></person-group>. <article-title>The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases</article-title>. <source>Part Fibre Toxicol.</source> (<year>2016</year>) <volume>13</volume>:<fpage>51</fpage>. <pub-id pub-id-type="doi">10.1186/s12989-016-0162-4</pub-id><?supplied-pmid 27650313?><pub-id pub-id-type="pmid">27650313</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoy</surname><given-names>RF</given-names></name><name><surname>Brims</surname><given-names>F</given-names></name></person-group>. <article-title>Occupational lung diseases in Australia</article-title>. <source>Med J Aust.</source> (<year>2017</year>) <volume>207</volume>:<fpage>443</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.5694/mja17.00601</pub-id><?supplied-pmid 29129163?><pub-id pub-id-type="pmid">29129163</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoet</surname><given-names>P</given-names></name><name><surname>Desvallees</surname><given-names>L</given-names></name><name><surname>Lison</surname><given-names>D</given-names></name></person-group>. <article-title>Do current OELs for silica protect from obstructive lung impairment? A critical review of epidemiological data</article-title>. <source>Crit Rev Toxicol.</source> (<year>2017</year>) <volume>47</volume>:<fpage>650</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1080/10408444.2017.1315363</pub-id><?supplied-pmid 28513256?><pub-id pub-id-type="pmid">28513256</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Hayashi</surname><given-names>H</given-names></name><name><surname>Mastuzaki</surname><given-names>H</given-names></name><name><surname>Kumagai-Takei</surname><given-names>N</given-names></name><name><surname>Otsuki</surname><given-names>T</given-names></name></person-group>. <article-title>Silicosis and autoimmunity</article-title>. <source>Curr Opin Allergy Clin Immunol.</source> (<year>2017</year>) <volume>17</volume>:<fpage>78</fpage>&#x02013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1097/ACI.0000000000000350</pub-id><?supplied-pmid 28177948?><pub-id pub-id-type="pmid">28177948</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoy</surname><given-names>RF</given-names></name><name><surname>Baird</surname><given-names>T</given-names></name><name><surname>Hammerschlag</surname><given-names>G</given-names></name><name><surname>Hart</surname><given-names>D</given-names></name><name><surname>Johnson</surname><given-names>AR</given-names></name><name><surname>King</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Artificial stone-associated silicosis: a rapidly emerging occupational lung disease</article-title>. <source>Occup Environ Med.</source> (<year>2018</year>) <volume>75</volume>:<fpage>3</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1136/oemed-2017-104428</pub-id><?supplied-pmid 28882991?><pub-id pub-id-type="pmid">28882991</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anlar</surname><given-names>HG</given-names></name><name><surname>Bacanli</surname><given-names>M</given-names></name><name><surname>Iritas</surname><given-names>S</given-names></name><name><surname>Bal</surname><given-names>C</given-names></name><name><surname>Kurt</surname><given-names>T</given-names></name><name><surname>Tutkun</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Effects of occupational silica exposure on OXIDATIVE stress and immune system parameters in ceramic workers in TURKEY</article-title>. <source>J Toxicol Environ Health A</source> (<year>2017</year>) <volume>80</volume>:<fpage>688</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1080/15287394.2017.1286923</pub-id><?supplied-pmid 28524802?><pub-id pub-id-type="pmid">28524802</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akgun</surname><given-names>M</given-names></name></person-group>. <article-title>Denim production and silicosis</article-title>. <source>Curr Opin Pulm Med.</source> (<year>2016</year>) <volume>22</volume>:<fpage>165</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1097/MCP.0000000000000249</pub-id><?supplied-pmid 26807688?><pub-id pub-id-type="pmid">26807688</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>CC</given-names></name><name><surname>Yu</surname><given-names>IT</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name></person-group>. <article-title>Silicosis</article-title>. <source>Lancet</source> (<year>2012</year>) <volume>379</volume>:<fpage>2008</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(12)60235-9</pub-id><?supplied-pmid 22534002?><pub-id pub-id-type="pmid">22534002</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ou</surname><given-names>L</given-names></name><name><surname>Song</surname><given-names>B</given-names></name><name><surname>Liang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Feng</surname><given-names>X</given-names></name><name><surname>Deng</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Toxicity of graphene-family nanoparticles: a general review of the origins and mechanisms</article-title>. <source>Part Fibre Toxicol.</source> (<year>2016</year>) <volume>13</volume>:<fpage>57</fpage>. <pub-id pub-id-type="doi">10.1186/s12989-016-0168-y</pub-id><?supplied-pmid 27799056?><pub-id pub-id-type="pmid">27799056</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollard</surname><given-names>KM</given-names></name></person-group>. <article-title>Silica, silicosis, and autoimmunity</article-title>. <source>Front Immunol.</source> (<year>2016</year>) <volume>7</volume>:<fpage>97</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2016.00097</pub-id><?supplied-pmid 27014276?><pub-id pub-id-type="pmid">27014276</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabolli</surname><given-names>V</given-names></name><name><surname>Lison</surname><given-names>D</given-names></name><name><surname>Huaux</surname><given-names>F</given-names></name></person-group>. <article-title>The complex cascade of cellular events governing inflammasome activation and IL-1&#x003b2; processing in response to inhaled particles</article-title>. <source>Part Fibre Toxicol.</source> (<year>2016</year>) <volume>13</volume>:<fpage>40</fpage>. <pub-id pub-id-type="doi">10.1186/s12989-016-0150-8</pub-id><?supplied-pmid 27519871?><pub-id pub-id-type="pmid">27519871</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakayama</surname><given-names>M</given-names></name></person-group>. <article-title>Macrophage recognition of crystals and nanoparticles</article-title>. <source>Front Immunol.</source> (<year>2018</year>) <volume>9</volume>:<fpage>103</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.00103</pub-id><?supplied-pmid 29434606?><pub-id pub-id-type="pmid">29434606</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadariya</surname><given-names>Y</given-names></name><name><surname>Menges</surname><given-names>CW</given-names></name><name><surname>Talarchek</surname><given-names>J</given-names></name><name><surname>Cai</surname><given-names>KQ</given-names></name><name><surname>Klein-Szanto</surname><given-names>AJ</given-names></name><name><surname>Pietrofesa</surname><given-names>RA</given-names></name><etal/></person-group>. <article-title>Inflammation-related IL1&#x003b2;/IL1R signaling promotes the development of asbestos-induced malignant mesothelioma</article-title>. <source>Cancer Prev Res (Phila)</source> (<year>2016</year>) <volume>9</volume>:<fpage>406</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1158/1940-6207.CAPR-15-0347</pub-id><?supplied-pmid 26935421?><pub-id pub-id-type="pmid">26935421</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hegde</surname><given-names>B</given-names></name><name><surname>Bodduluri</surname><given-names>SR</given-names></name><name><surname>Satpathy</surname><given-names>SR</given-names></name><name><surname>Alghsham</surname><given-names>RS</given-names></name><name><surname>Jala</surname><given-names>VR</given-names></name><name><surname>Uriarte</surname><given-names>SM</given-names></name><etal/></person-group>. <article-title>Inflammasome-independent leukotriene B4 production drives crystalline silica-induced sterile inflammation</article-title>. <source>J Immunol.</source> (<year>2018</year>) <volume>200</volume>:<fpage>3556</fpage>&#x02013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1701504</pub-id><?supplied-pmid 29610142?><pub-id pub-id-type="pmid">29610142</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Yao</surname><given-names>Y</given-names></name><name><surname>Su</surname><given-names>X</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>X</given-names></name><name><surname>Xie</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Comparative RNA-Seq transcriptome analysis on silica induced pulmonary inflammation and fibrosis in mice silicosis model</article-title>. <source>J Appl Toxicol.</source> (<year>2018</year>) <volume>38</volume>:<fpage>773</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1002/jat.3587</pub-id><?supplied-pmid 29341224?><pub-id pub-id-type="pmid">29341224</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alsaleh</surname><given-names>NB</given-names></name><name><surname>Brown</surname><given-names>JM</given-names></name></person-group>. <article-title>Immune responses to engineered nanomaterials: current understanding and challenges</article-title>. <source>Curr Opin Toxicol.</source> (<year>2018</year>) <volume>10</volume>:<fpage>8</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.cotox.2017.11.011</pub-id><?supplied-pmid 29577105?><pub-id pub-id-type="pmid">29577105</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiraku</surname><given-names>Y</given-names></name><name><surname>Kawanishi</surname><given-names>S</given-names></name><name><surname>Ichinose</surname><given-names>T</given-names></name><name><surname>Murata</surname><given-names>M</given-names></name></person-group>. <article-title>The role of iNOS-mediated DNA damage in infection- and asbestos-induced carcinogenesis</article-title>. <source>Ann N Y Acad Sci.</source> (<year>2010</year>) <volume>1203</volume>:<fpage>15</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.2010.05602.x</pub-id><?supplied-pmid 20716278?><pub-id pub-id-type="pmid">20716278</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mossman</surname><given-names>BT</given-names></name><name><surname>Shukla</surname><given-names>A</given-names></name><name><surname>Heintz</surname><given-names>NH</given-names></name><name><surname>Verschraegen</surname><given-names>CF</given-names></name><name><surname>Thomas</surname><given-names>A</given-names></name><name><surname>Hassan</surname><given-names>R</given-names></name></person-group>. <article-title>New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas</article-title>. <source>Am J Pathol.</source> (<year>2013</year>) <volume>182</volume>:<fpage>1065</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajpath.2012.12.028</pub-id><?supplied-pmid 23395095?><pub-id pub-id-type="pmid">23395095</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winkler</surname><given-names>HC</given-names></name><name><surname>Kornprobst</surname><given-names>J</given-names></name><name><surname>Wick</surname><given-names>P</given-names></name><name><surname>von Moos</surname><given-names>LM</given-names></name><name><surname>Trantakis</surname><given-names>I</given-names></name><name><surname>Schraner</surname><given-names>EM</given-names></name><etal/></person-group>. <article-title>MyD88-dependent pro-interleukin-1&#x003b2; induction in dendritic cells exposed to food-grade synthetic amorphous silica</article-title>. <source>Part Fibre Toxicol.</source> (<year>2017</year>) <volume>14</volume>:<fpage>21</fpage>. <pub-id pub-id-type="doi">10.1186/s12989-017-0202-8</pub-id><?supplied-pmid 28645296?><pub-id pub-id-type="pmid">28645296</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thakur</surname><given-names>C</given-names></name><name><surname>Wolfarth</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Battelli</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Oncoprotein mdig contributes to silica-induced pulmonary fibrosis by altering balance between Th17 and Treg T cells</article-title>. <source>Oncotarget</source> (<year>2015</year>) <volume>6</volume>:<fpage>3722</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.2914</pub-id><?supplied-pmid 25669985?><pub-id pub-id-type="pmid">25669985</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo Re</surname><given-names>S</given-names></name><name><surname>Dumoutier</surname><given-names>L</given-names></name><name><surname>Couillin</surname><given-names>I</given-names></name><name><surname>Van Vyve</surname><given-names>C</given-names></name><name><surname>Yakoub</surname><given-names>Y</given-names></name><name><surname>Uwambayinema</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>IL-17A-producing gammadelta T and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis</article-title>. <source>J Immunol.</source> (<year>2010</year>) <volume>184</volume>:<fpage>6367</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0900459</pub-id><?supplied-pmid 20421647?><pub-id pub-id-type="pmid">20421647</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Re</surname><given-names>SL</given-names></name><name><surname>Giordano</surname><given-names>G</given-names></name><name><surname>Yakoub</surname><given-names>Y</given-names></name><name><surname>Devosse</surname><given-names>R</given-names></name><name><surname>Uwambayinema</surname><given-names>F</given-names></name><name><surname>Couillin</surname><given-names>I</given-names></name><etal/></person-group>. <article-title>Uncoupling between inflammatory and fibrotic responses to silica: evidence from MyD88 knockout mice</article-title>. <source>PLoS ONE</source> (<year>2014</year>) <volume>9</volume>:<fpage>e99383</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0099383</pub-id><?supplied-pmid 25050810?><pub-id pub-id-type="pmid">25050810</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huaux</surname><given-names>F</given-names></name><name><surname>Lo Re</surname><given-names>S</given-names></name><name><surname>Giordano</surname><given-names>G</given-names></name><name><surname>Uwambayinema</surname><given-names>F</given-names></name><name><surname>Devosse</surname><given-names>R</given-names></name><name><surname>Yakoub</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>IL-1alpha induces CD11b(low) alveolar macrophage proliferation and maturation during granuloma formation</article-title>. <source>J Pathol.</source> (<year>2015</year>) <volume>235</volume>:<fpage>698</fpage>&#x02013;<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1002/path.4487</pub-id><?supplied-pmid 25421226?><pub-id pub-id-type="pmid">25421226</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vietti</surname><given-names>G</given-names></name><name><surname>Lison</surname><given-names>D</given-names></name><name><surname>van den Brule</surname><given-names>S</given-names></name></person-group>. <article-title>Mechanisms of lung fibrosis induced by carbon nanotubes: towards an Adverse Outcome Pathway (AOP)</article-title>. <source>Part Fibre Toxicol.</source> (<year>2016</year>) <volume>13</volume>:<fpage>11</fpage>. <pub-id pub-id-type="doi">10.1186/s12989-016-0123-y</pub-id><?supplied-pmid 26926090?><pub-id pub-id-type="pmid">26926090</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Hogberg</surname><given-names>J</given-names></name><name><surname>Stenius</surname><given-names>U</given-names></name></person-group>. <article-title>ATM-activated autotaxin (ATX) propagates inflammation and DNA damage in lung epithelial cells: a new mode of action for silica-induced DNA damage?</article-title>
<source>Carcinogenesis</source> (<year>2017</year>) <volume>38</volume>:<fpage>1196</fpage>&#x02013;<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1093/carcin/bgx100</pub-id><?supplied-pmid 28968864?><pub-id pub-id-type="pmid">28968864</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferro</surname><given-names>A</given-names></name><name><surname>Zebedeo</surname><given-names>CN</given-names></name><name><surname>Davis</surname><given-names>C</given-names></name><name><surname>Ng</surname><given-names>KW</given-names></name><name><surname>Pfau</surname><given-names>JC</given-names></name></person-group>. <article-title>Amphibole, but not chrysotile, asbestos induces anti-nuclear autoantibodies and IL-17 in C57BL/6 mice</article-title>. <source>J Immunotoxicol.</source> (<year>2014</year>) <volume>11</volume>:<fpage>283</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.3109/1547691X.2013.847510</pub-id><?supplied-pmid 24164284?><pub-id pub-id-type="pmid">24164284</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zebedeo</surname><given-names>CN</given-names></name><name><surname>Davis</surname><given-names>C</given-names></name><name><surname>Pena</surname><given-names>C</given-names></name><name><surname>Ng</surname><given-names>KW</given-names></name><name><surname>Pfau</surname><given-names>JC</given-names></name></person-group>. <article-title>Erionite induces production of autoantibodies and IL-17 in C57BL/6 mice</article-title>. <source>Toxicol Appl Pharmacol.</source> (<year>2014</year>) <volume>275</volume>:<fpage>257</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.taap.2014.01.018</pub-id><?supplied-pmid 24518925?><pub-id pub-id-type="pmid">24518925</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bates</surname><given-names>MA</given-names></name><name><surname>Brandenberger</surname><given-names>C</given-names></name><name><surname>Langohr</surname><given-names>I</given-names></name><name><surname>Kumagai</surname><given-names>K</given-names></name><name><surname>Harkema</surname><given-names>JR</given-names></name><name><surname>Holian</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Silica triggers inflammation and ectopic lymphoid neogenesis in the lungs in parallel with accelerated onset of systemic autoimmunity and glomerulonephritis in the lupus-prone NZBWF1 mouse</article-title>. <source>PLoS ONE</source> (<year>2015</year>) <volume>10</volume>:<fpage>e0125481</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0125481</pub-id><?supplied-pmid 25978333?><pub-id pub-id-type="pmid">25978333</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname><given-names>R</given-names></name><name><surname>Trout</surname><given-names>KL</given-names></name><name><surname>Jessop</surname><given-names>F</given-names></name><name><surname>Harkema</surname><given-names>JR</given-names></name><name><surname>Holian</surname><given-names>A</given-names></name></person-group>. <article-title>Imipramine blocks acute silicosis in a mouse model</article-title>. <source>Part Fibre Toxicol.</source> (<year>2017</year>) <volume>14</volume>:<fpage>36</fpage>. <pub-id pub-id-type="doi">10.1186/s12989-017-0217-1</pub-id><?supplied-pmid 28893276?><pub-id pub-id-type="pmid">28893276</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname><given-names>R</given-names></name><name><surname>Ding</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Xia</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>B</given-names></name></person-group>. <article-title>Proteomic profiling change during the early development of silicosis disease</article-title>. <source>J Thorac Dis.</source> (<year>2016</year>) <volume>8</volume>:<fpage>329</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.21037/jtd.2016.02.46</pub-id><?supplied-pmid 27076927?><pub-id pub-id-type="pmid">27076927</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comar</surname><given-names>M</given-names></name><name><surname>Zanotta</surname><given-names>N</given-names></name><name><surname>Bonotti</surname><given-names>A</given-names></name><name><surname>Tognon</surname><given-names>M</given-names></name><name><surname>Negro</surname><given-names>C</given-names></name><name><surname>Cristaudo</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Increased levels of C-C chemokine RANTES in asbestos exposed workers and in malignant mesothelioma patients from an hyperendemic area</article-title>. <source>PLoS ONE</source> (<year>2014</year>) <volume>9</volume>:<fpage>e104848</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0104848</pub-id><?supplied-pmid 25162674?><pub-id pub-id-type="pmid">25162674</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polatli</surname><given-names>M</given-names></name><name><surname>Tuna</surname><given-names>HT</given-names></name><name><surname>Yenisey</surname><given-names>C</given-names></name><name><surname>Serter</surname><given-names>M</given-names></name><name><surname>Cildag</surname><given-names>O</given-names></name></person-group>. <article-title>Lung function and IFN-gamma levels in the sera of silica-exposed workers</article-title>. <source>J Interferon Cytokine Res.</source> (<year>2008</year>) <volume>28</volume>:<fpage>311</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1089/jir.2007.0093</pub-id><?supplied-pmid 18547161?><pub-id pub-id-type="pmid">18547161</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>BW</given-names></name><name><surname>Rose</surname><given-names>AH</given-names></name><name><surname>Hayes</surname><given-names>A</given-names></name><name><surname>Musk</surname><given-names>AW</given-names></name></person-group>. <article-title>Increased pulmonary gamma interferon production in asbestosis</article-title>. <source>Am Rev Respir Dis.</source> (<year>1988</year>) <volume>138</volume>:<fpage>278</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1164/ajrccm/138.2.278</pub-id><?supplied-pmid 3143284?><pub-id pub-id-type="pmid">3143284</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenberg</surname><given-names>MI</given-names></name><name><surname>Waksman</surname><given-names>J</given-names></name><name><surname>Curtis</surname><given-names>J</given-names></name></person-group>. <article-title>Silicosis: a review</article-title>. <source>Dis Mon.</source> (<year>2007</year>) <volume>53</volume>:<fpage>394</fpage>&#x02013;<lpage>416</lpage>. <pub-id pub-id-type="doi">10.1016/j.disamonth.2007.09.020</pub-id><?supplied-pmid 17976433?><pub-id pub-id-type="pmid">17976433</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>C</given-names></name><name><surname>Alfonso</surname><given-names>H</given-names></name><name><surname>Woo</surname><given-names>S</given-names></name><name><surname>Olsen</surname><given-names>N</given-names></name><name><surname>Bill Musk</surname><given-names>AW</given-names></name><name><surname>Robinson</surname><given-names>BW</given-names></name><etal/></person-group>. <article-title>Effect of NSAIDS and COX-2 inhibitors on the incidence and severity of asbestos-induced malignant mesothelioma: evidence from an animal model and a human cohort</article-title>. <source>Lung Cancer</source> (<year>2014</year>) <volume>86</volume>:<fpage>29</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.lungcan.2014.08.005</pub-id><?supplied-pmid 25175318?><pub-id pub-id-type="pmid">25175318</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baird</surname><given-names>T</given-names></name><name><surname>Putt</surname><given-names>M</given-names></name><name><surname>Dettrick</surname><given-names>A</given-names></name></person-group>. <article-title>A stonemason with accelerated silicosis in the setting of tumour necrosis factor alpha inhibitor therapy</article-title>. <source>Respirol Case Rep.</source> (<year>2016</year>) <volume>4</volume>:<fpage>e00171</fpage>. <pub-id pub-id-type="doi">10.1002/rcr2.171</pub-id><?supplied-pmid 27516887?><pub-id pub-id-type="pmid">27516887</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Zhuang</surname><given-names>H</given-names></name><name><surname>Gu</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>IL-10-Producing CD1d<sup>hi</sup>CD5<sup>+</sup> regulatory B cells may play a critical role in modulating immune homeostasis in silicosis patients</article-title>. <source>Front Immunol.</source> (<year>2017</year>) <volume>8</volume>:<fpage>110</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.00110</pub-id><?supplied-pmid 28243231?><pub-id pub-id-type="pmid">28243231</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beamer</surname><given-names>CA</given-names></name><name><surname>Seaver</surname><given-names>BP</given-names></name><name><surname>Shepherd</surname><given-names>DM</given-names></name></person-group>. <article-title>Aryl hydrocarbon receptor (AhR) regulates silica-induced inflammation but not fibrosis</article-title>. <source>Toxicol Sci.</source> (<year>2012</year>) <volume>126</volume>:<fpage>554</fpage>&#x02013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1093/toxsci/kfs024</pub-id><?supplied-pmid 22273745?><pub-id pub-id-type="pmid">22273745</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shvedova</surname><given-names>AA</given-names></name><name><surname>Kisin</surname><given-names>ER</given-names></name><name><surname>Murray</surname><given-names>AR</given-names></name><name><surname>Kommineni</surname><given-names>C</given-names></name><name><surname>Castranova</surname><given-names>V</given-names></name><name><surname>Fadeel</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Increased accumulation of neutrophils and decreased fibrosis in the lung of NADPH oxidase-deficient C57BL/6 mice exposed to carbon nanotubes</article-title>. <source>Toxicol Appl Pharmacol.</source> (<year>2008</year>) <volume>231</volume>:<fpage>235</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.taap.2008.04.018</pub-id><?supplied-pmid 18534653?><pub-id pub-id-type="pmid">18534653</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brass</surname><given-names>DM</given-names></name><name><surname>McGee</surname><given-names>SP</given-names></name><name><surname>Dunkel</surname><given-names>MK</given-names></name><name><surname>Reilly</surname><given-names>SM</given-names></name><name><surname>Tobolewski</surname><given-names>JM</given-names></name><name><surname>Sabo-Attwood</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Gender influences the response to experimental silica-induced lung fibrosis in mice</article-title>. <source>Am J Physiol Lung Cell Mol Physiol.</source> (<year>2010</year>) <volume>299</volume>:<fpage>L664</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1152/ajplung.00389.2009</pub-id><?supplied-pmid 20729388?><pub-id pub-id-type="pmid">20729388</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>J</given-names></name><name><surname>Porter</surname><given-names>DW</given-names></name><name><surname>Batteli</surname><given-names>LA</given-names></name><name><surname>Wolfarth</surname><given-names>MG</given-names></name><name><surname>Richardson</surname><given-names>DL</given-names></name><name><surname>Ma</surname><given-names>Q</given-names></name></person-group>. <article-title>Pathologic and molecular profiling of rapid-onset fibrosis and inflammation induced by multi-walled carbon nanotubes</article-title>. <source>Arch Toxicol.</source> (<year>2015</year>) <volume>89</volume>:<fpage>621</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1007/s00204-014-1428-y</pub-id><?supplied-pmid 25510677?><pub-id pub-id-type="pmid">25510677</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabolli</surname><given-names>V</given-names></name><name><surname>Lo Re</surname><given-names>S</given-names></name><name><surname>Uwambayinema</surname><given-names>F</given-names></name><name><surname>Yakoub</surname><given-names>Y</given-names></name><name><surname>Lison</surname><given-names>D</given-names></name><name><surname>Huaux</surname><given-names>F</given-names></name></person-group>. <article-title>Lung fibrosis induced by crystalline silica particles is uncoupled from lung inflammation in NMRI mice</article-title>. <source>Toxicol Lett.</source> (<year>2011</year>) <volume>203</volume>:<fpage>127</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxlet.2011.03.009</pub-id><?supplied-pmid 21414392?><pub-id pub-id-type="pmid">21414392</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbarin</surname><given-names>V</given-names></name><name><surname>Nihoul</surname><given-names>A</given-names></name><name><surname>Misson</surname><given-names>P</given-names></name><name><surname>Arras</surname><given-names>M</given-names></name><name><surname>Delos</surname><given-names>M</given-names></name><name><surname>Leclercq</surname><given-names>I</given-names></name><etal/></person-group>. <article-title>The role of pro- and anti-inflammatory responses in silica-induced lung fibrosis</article-title>. <source>Respir Res.</source> (<year>2005</year>) <volume>6</volume>:<fpage>112</fpage>. <pub-id pub-id-type="doi">10.1186/1465-9921-6-112</pub-id><?supplied-pmid 16212659?><pub-id pub-id-type="pmid">16212659</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rydman</surname><given-names>EM</given-names></name><name><surname>Ilves</surname><given-names>M</given-names></name><name><surname>Vanhala</surname><given-names>E</given-names></name><name><surname>Vippola</surname><given-names>M</given-names></name><name><surname>Lehto</surname><given-names>M</given-names></name><name><surname>Kinaret</surname><given-names>PA</given-names></name><etal/></person-group>. <article-title>A single aspiration of rod-like carbon nanotubes induces asbestos-like pulmonary inflammation mediated in part by the IL-1 receptor</article-title>. <source>Toxicol Sci.</source> (<year>2015</year>) <volume>147</volume>:<fpage>140</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1093/toxsci/kfv112</pub-id><?supplied-pmid 26048651?><pub-id pub-id-type="pmid">26048651</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>L</given-names></name><name><surname>Weng</surname><given-names>D</given-names></name><name><surname>Dai</surname><given-names>W</given-names></name><name><surname>Tang</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Th17 can regulate silica-induced lung inflammation through an IL-1&#x003b2;-dependent mechanism</article-title>. <source>J Cell Mol Med.</source> (<year>2014</year>) <volume>18</volume>:<fpage>1773</fpage>&#x02013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1111/jcmm.12341</pub-id><?supplied-pmid 25091058?><pub-id pub-id-type="pmid">25091058</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Gu</surname><given-names>N</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>T</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Rong</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Neutralization of interleukin-1 beta attenuates silica-induced lung inflammation and fibrosis in C57BL/6 mice</article-title>. <source>Arch Toxicol.</source> (<year>2013</year>) <volume>87</volume>:<fpage>1963</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1007/s00204-013-1063-z</pub-id><?supplied-pmid 23640035?><pub-id pub-id-type="pmid">23640035</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>GS</given-names></name><name><surname>Pfeiffer</surname><given-names>LM</given-names></name><name><surname>Hemenway</surname><given-names>DR</given-names></name><name><surname>Rincon</surname><given-names>M</given-names></name></person-group>. <article-title>Interleukin-12 is not essential for silicosis in mice</article-title>. <source>Part Fibre Toxicol.</source> (<year>2006</year>) <volume>3</volume>:<fpage>2</fpage>. <pub-id pub-id-type="doi">10.1186/1743-8977-3-2</pub-id><?supplied-pmid 16396683?><pub-id pub-id-type="pmid">16396683</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satpathy</surname><given-names>SR</given-names></name><name><surname>Jala</surname><given-names>VR</given-names></name><name><surname>Bodduluri</surname><given-names>SR</given-names></name><name><surname>Krishnan</surname><given-names>E</given-names></name><name><surname>Hegde</surname><given-names>B</given-names></name><name><surname>Hoyle</surname><given-names>GW</given-names></name><etal/></person-group>. <article-title>Crystalline silica-induced leukotriene B4-dependent inflammation promotes lung tumour growth</article-title>. <source>Nat Commun.</source> (<year>2015</year>) <volume>6</volume>:<fpage>7064</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms8064</pub-id><?supplied-pmid 25923988?><pub-id pub-id-type="pmid">25923988</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>MT</given-names></name><name><surname>Tschopp</surname><given-names>J</given-names></name><name><surname>Moller</surname><given-names>A</given-names></name><name><surname>Smyth</surname><given-names>MJ</given-names></name></person-group>. <article-title>NLRP3 promotes inflammation-induced skin cancer but is dispensable for asbestos-induced mesothelioma</article-title>. <source>Immunol Cell Biol.</source> (<year>2012</year>) <volume>90</volume>:<fpage>983</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/icb.2012.46</pub-id><?supplied-pmid 23010873?><pub-id pub-id-type="pmid">23010873</pub-id></mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>C</given-names></name><name><surname>Walsh</surname><given-names>A</given-names></name><name><surname>Larma</surname><given-names>I</given-names></name><name><surname>O'Halloran</surname><given-names>S</given-names></name><name><surname>Nowak</surname><given-names>AK</given-names></name><name><surname>Lake</surname><given-names>RA</given-names></name></person-group>. <article-title>MexTAg mice exposed to asbestos develop cancer that faithfully replicates key features of the pathogenesis of human mesothelioma</article-title>. <source>Eur J Cancer</source> (<year>2011</year>) <volume>47</volume>:<fpage>151</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejca.2010.08.015</pub-id><?supplied-pmid 20850297?><pub-id pub-id-type="pmid">20850297</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huaux</surname><given-names>F</given-names></name><name><surname>Louahed</surname><given-names>J</given-names></name><name><surname>Hudspith</surname><given-names>B</given-names></name><name><surname>Meredith</surname><given-names>C</given-names></name><name><surname>Delos</surname><given-names>M</given-names></name><name><surname>Renauld</surname><given-names>JC</given-names></name><etal/></person-group>. <article-title>Role of interleukin-10 in the lung response to silica in mice</article-title>. <source>Am J Respir Cell Mol Biol.</source> (<year>1998</year>) <volume>18</volume>:<fpage>51</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1165/ajrcmb.18.1.2911</pub-id><?supplied-pmid 9448045?><pub-id pub-id-type="pmid">9448045</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>EJ</given-names></name><name><surname>Roh</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>SN</given-names></name><name><surname>Kang</surname><given-names>MS</given-names></name><name><surname>Han</surname><given-names>YA</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>A single intratracheal instillation of single-walled carbon nanotubes induced early lung fibrosis and subchronic tissue damage in mice</article-title>. <source>Arch Toxicol.</source> (<year>2011</year>) <volume>85</volume>:<fpage>1121</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1007/s00204-011-0655-8</pub-id><?supplied-pmid 21472445?><pub-id pub-id-type="pmid">21472445</pub-id></mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murthy</surname><given-names>S</given-names></name><name><surname>Larson-Casey</surname><given-names>JL</given-names></name><name><surname>Ryan</surname><given-names>AJ</given-names></name><name><surname>He</surname><given-names>C</given-names></name><name><surname>Kobzik</surname><given-names>L</given-names></name><name><surname>Carter</surname><given-names>AB</given-names></name></person-group>. <article-title>Alternative activation of macrophages and pulmonary fibrosis are modulated by scavenger receptor, macrophage receptor with collagenous structure</article-title>. <source>FASEB J.</source> (<year>2015</year>) <volume>29</volume>:<fpage>3527</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1096/fj.15-271304</pub-id><?supplied-pmid 25953850?><pub-id pub-id-type="pmid">25953850</pub-id></mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>JJ</given-names></name><name><surname>Bateman</surname><given-names>HR</given-names></name><name><surname>Stover</surname><given-names>A</given-names></name><name><surname>Gomez</surname><given-names>G</given-names></name><name><surname>Norton</surname><given-names>SK</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Fullerene nanomaterials inhibit the allergic response</article-title>. <source>J Immunol.</source> (<year>2007</year>) <volume>179</volume>:<fpage>665</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.179.1.665</pub-id><?supplied-pmid 17579089?><pub-id pub-id-type="pmid">17579089</pub-id></mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ilinskaya</surname><given-names>AN</given-names></name><name><surname>Dobrovolskaia</surname><given-names>MA</given-names></name></person-group>. <article-title>Immunosuppressive and anti-inflammatory properties of engineered nanomaterials</article-title>. <source>Br J Pharmacol.</source> (<year>2014</year>) <volume>171</volume>:<fpage>3988</fpage>&#x02013;<lpage>4000</lpage>. <pub-id pub-id-type="doi">10.1111/bph.12722</pub-id><?supplied-pmid 24724793?><pub-id pub-id-type="pmid">24724793</pub-id></mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngobili</surname><given-names>TA</given-names></name><name><surname>Daniele</surname><given-names>MA</given-names></name></person-group>. <article-title>Nanoparticles and direct immunosuppression</article-title>. <source>Exp Biol Med (Maywood)</source> (<year>2016</year>) <volume>241</volume>:<fpage>1064</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1177/1535370216650053</pub-id><?supplied-pmid 27229901?><pub-id pub-id-type="pmid">27229901</pub-id></mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>LA</given-names></name><name><surname>Lauer</surname><given-names>FT</given-names></name><name><surname>Burchiel</surname><given-names>SW</given-names></name><name><surname>McDonald</surname><given-names>JD</given-names></name></person-group>. <article-title>Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice</article-title>. <source>Nat Nanotechnol.</source> (<year>2009</year>) <volume>4</volume>:<fpage>451</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/nnano.2009.151</pub-id><?supplied-pmid 19581899?><pub-id pub-id-type="pmid">19581899</pub-id></mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo Re</surname><given-names>S</given-names></name><name><surname>Lecocq</surname><given-names>M</given-names></name><name><surname>Uwambayinema</surname><given-names>F</given-names></name><name><surname>Yakoub</surname><given-names>Y</given-names></name><name><surname>Delos</surname><given-names>M</given-names></name><name><surname>Demoulin</surname><given-names>JB</given-names></name><etal/></person-group>. <article-title>Platelet-derived growth factor-producing CD4<sup>+</sup> Foxp3<sup>+</sup> regulatory T lymphocytes promote lung fibrosis</article-title>. <source>Am J Respir Crit Care Med.</source> (<year>2011</year>) <volume>184</volume>:<fpage>1270</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.201103-0516OC</pub-id><?supplied-pmid 21868503?><pub-id pub-id-type="pmid">21868503</pub-id></mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hess</surname><given-names>KL</given-names></name><name><surname>Oh</surname><given-names>E</given-names></name><name><surname>Tostanoski</surname><given-names>LH</given-names></name><name><surname>Andorko</surname><given-names>JI</given-names></name><name><surname>Susumu</surname><given-names>K</given-names></name><name><surname>Deschamps</surname><given-names>JR</given-names></name><etal/></person-group>. <article-title>Engineering immunological tolerance using quantum dots to tune the density of self-antigen display</article-title>. <source>Adv Funct Mater.</source> (<year>2017</year>) <volume>27</volume>:<fpage>1700290</fpage>. <pub-id pub-id-type="doi">10.1002/adfm.201700290</pub-id><?supplied-pmid 29503604?><pub-id pub-id-type="pmid">29503604</pub-id></mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Weng</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>Q</given-names></name><etal/></person-group>. <article-title>CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> regulatory T cells depletion may attenuate the development of silica-induced lung fibrosis in mice</article-title>. <source>PLoS ONE</source> (<year>2010</year>) <volume>5</volume>:<fpage>e15404</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0015404</pub-id><?supplied-pmid 21072213?><pub-id pub-id-type="pmid">21072213</pub-id></mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ying</surname><given-names>C</given-names></name><name><surname>Maeda</surname><given-names>M</given-names></name><name><surname>Nishimura</surname><given-names>Y</given-names></name><name><surname>Kumagai-Takei</surname><given-names>N</given-names></name><name><surname>Hayashi</surname><given-names>H</given-names></name><name><surname>Matsuzaki</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Enhancement of regulatory T cell-like suppressive function in MT-2 by long-term and low-dose exposure to asbestos</article-title>. <source>Toxicology</source> (<year>2015</year>) <volume>338</volume>:<fpage>86</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.tox.2015.10.005</pub-id><?supplied-pmid 26505785?><pub-id pub-id-type="pmid">26505785</pub-id></mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shvedova</surname><given-names>AA</given-names></name><name><surname>Tkach</surname><given-names>AV</given-names></name><name><surname>Kisin</surname><given-names>ER</given-names></name><name><surname>Khaliullin</surname><given-names>T</given-names></name><name><surname>Stanley</surname><given-names>S</given-names></name><name><surname>Gutkin</surname><given-names>DW</given-names></name><etal/></person-group>. <article-title>Carbon nanotubes enhance metastatic growth of lung carcinoma via up-regulation of myeloid-derived suppressor cells</article-title>. <source>Small</source> (<year>2013</year>) <volume>9</volume>:<fpage>1691</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1002/smll.201201470</pub-id><?supplied-pmid 22996965?><pub-id pub-id-type="pmid">22996965</pub-id></mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebrun</surname><given-names>A</given-names></name><name><surname>Lo Re</surname><given-names>S</given-names></name><name><surname>Chantry</surname><given-names>M</given-names></name><name><surname>Izquierdo Carerra</surname><given-names>X</given-names></name><name><surname>Uwambayinema</surname><given-names>F</given-names></name><name><surname>Ricci</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>CCR2<sup>+</sup> monocytic myeloid-derived suppressor cells (M-MDSCs) inhibit collagen degradation and promote lung fibrosis by producing transforming growth factor-beta1</article-title>. <source>J Pathol.</source> (<year>2017</year>) <volume>243</volume>:<fpage>320</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1002/path.4956</pub-id><?supplied-pmid 28799208?><pub-id pub-id-type="pmid">28799208</pub-id></mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shvedova</surname><given-names>AA</given-names></name><name><surname>Kisin</surname><given-names>ER</given-names></name><name><surname>Yanamala</surname><given-names>N</given-names></name><name><surname>Tkach</surname><given-names>AV</given-names></name><name><surname>Gutkin</surname><given-names>DW</given-names></name><name><surname>Star</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>MDSC and TGFbeta are required for facilitation of tumor growth in the lungs of mice exposed to carbon nanotubes</article-title>. <source>Cancer Res.</source> (<year>2015</year>) <volume>75</volume>:<fpage>1615</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-14-2376</pub-id><?supplied-pmid 25744719?><pub-id pub-id-type="pmid">25744719</pub-id></mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiang</surname><given-names>GA</given-names></name><name><surname>Zhang</surname><given-names>YD</given-names></name><name><surname>Su</surname><given-names>CC</given-names></name><name><surname>Ma</surname><given-names>YQ</given-names></name><name><surname>Li</surname><given-names>YM</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Dynamic changes of mononuclear phagocytes in circulating, pulmonary alveolar and interstitial compartments in a mouse model of experimental silicosis</article-title>. <source>Inhal Toxicol.</source> (<year>2016</year>) <volume>28</volume>:<fpage>393</fpage>&#x02013;<lpage>402</lpage>. <pub-id pub-id-type="doi">10.1080/08958378.2016.1188186</pub-id><?supplied-pmid 27240636?><pub-id pub-id-type="pmid">27240636</pub-id></mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>Q</given-names></name></person-group>. <article-title>Macrophage polarization and activation at the interface of multi-walled carbon nanotube-induced pulmonary inflammation and fibrosis</article-title>. <source>Nanotoxicology</source> (<year>2018</year>) <volume>12</volume>:<fpage>153</fpage>&#x02013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1080/17435390.2018.1425501</pub-id><?supplied-pmid 29338488?><pub-id pub-id-type="pmid">29338488</pub-id></mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helmig</surname><given-names>S</given-names></name><name><surname>Belwe</surname><given-names>A</given-names></name><name><surname>Schneider</surname><given-names>J</given-names></name></person-group>. <article-title>Association of transforming growth factor beta1 gene polymorphisms and asbestos-induced fibrosis and tumors</article-title>. <source>J Investig Med.</source> (<year>2009</year>) <volume>57</volume>:<fpage>655</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.2310/JIM.0b013e3181a4f32a</pub-id><?supplied-pmid 19349911?><pub-id pub-id-type="pmid">19349911</pub-id></mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jagirdar</surname><given-names>J</given-names></name><name><surname>Begin</surname><given-names>R</given-names></name><name><surname>Dufresne</surname><given-names>A</given-names></name><name><surname>Goswami</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>TC</given-names></name><name><surname>Rom</surname><given-names>WN</given-names></name></person-group>. <article-title>Transforming growth factor-beta (TGF-beta) in silicosis</article-title>. <source>Am J Respir Crit Care Med.</source> (<year>1996</year>) <volume>154</volume>(<issue>4 Pt 1</issue>):<fpage>1076</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1164/ajrccm.154.4.8887610</pub-id><?supplied-pmid 8887610?><pub-id pub-id-type="pmid">8887610</pub-id></mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuzaki</surname><given-names>H</given-names></name><name><surname>Kumagai-Takei</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Maeda</surname><given-names>M</given-names></name><name><surname>Sada</surname><given-names>N</given-names></name><name><surname>Hatayama</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Search for biomarkers of asbestos exposure and asbestos-induced cancers in investigations of the immunological effects of asbestos</article-title>. <source>Environ Health Prev Med.</source> (<year>2017</year>) <volume>22</volume>:<fpage>53</fpage>. <pub-id pub-id-type="doi">10.1186/s12199-017-0661-4</pub-id><?supplied-pmid 29165150?><pub-id pub-id-type="pmid">29165150</pub-id></mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Karjalainen</surname><given-names>A</given-names></name><name><surname>Koskinen</surname><given-names>H</given-names></name><name><surname>Vainio</surname><given-names>H</given-names></name><name><surname>Pukkala</surname><given-names>E</given-names></name><name><surname>Hemminki</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Serum growth factors in asbestosis patients</article-title>. <source>Biomarkers</source> (<year>2009</year>) <volume>14</volume>:<fpage>61</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1080/13547500802676868</pub-id><?supplied-pmid 19283526?><pub-id pub-id-type="pmid">19283526</pub-id></mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khalil</surname><given-names>N</given-names></name><name><surname>O'Connor</surname><given-names>RN</given-names></name><name><surname>Flanders</surname><given-names>KC</given-names></name><name><surname>Unruh</surname><given-names>H</given-names></name></person-group>. <article-title>TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study</article-title>. <source>Am J Respir Cell Mol Biol.</source> (<year>1996</year>) <volume>14</volume>:<fpage>131</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1165/ajrcmb.14.2.8630262</pub-id><?supplied-pmid 8630262?><pub-id pub-id-type="pmid">8630262</pub-id></mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>Q</given-names></name></person-group>. <article-title>Osteopontin enhances multi-walled carbon nanotube-triggered lung fibrosis by promoting TGF-beta1 activation and myofibroblast differentiation</article-title>. <source>Part Fibre Toxicol.</source> (<year>2017</year>) <volume>14</volume>:<fpage>18</fpage>. <pub-id pub-id-type="doi">10.1186/s12989-017-0198-0</pub-id><?supplied-pmid 28595626?><pub-id pub-id-type="pmid">28595626</pub-id></mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polimeni</surname><given-names>M</given-names></name><name><surname>Gulino</surname><given-names>GR</given-names></name><name><surname>Gazzano</surname><given-names>E</given-names></name><name><surname>Kopecka</surname><given-names>J</given-names></name><name><surname>Marucco</surname><given-names>A</given-names></name><name><surname>Fenoglio</surname><given-names>I</given-names></name><etal/></person-group>. <article-title>Multi-walled carbon nanotubes directly induce epithelial-mesenchymal transition in human bronchial epithelial cells via the TGF-beta-mediated Akt/GSK-3beta/SNAIL-1 signalling pathway</article-title>. <source>Part Fibre Toxicol.</source> (<year>2016</year>) <volume>13</volume>:<fpage>27</fpage>. <pub-id pub-id-type="doi">10.1186/s12989-016-0138-4</pub-id><?supplied-pmid 27251132?><pub-id pub-id-type="pmid">27251132</pub-id></mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>F</given-names></name><name><surname>Ye</surname><given-names>Q</given-names></name><name><surname>Ning</surname><given-names>W</given-names></name></person-group>. <article-title>Follistatin like-1 aggravates silica-induced mouse lung injury</article-title>. <source>Sci Rep.</source> (<year>2017</year>) <volume>7</volume>:<fpage>399</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-00478-0</pub-id><?supplied-pmid 28341862?><pub-id pub-id-type="pmid">28341862</pub-id></mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>He</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Gan</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Specifically formed corona on silica nanoparticles enhances transforming growth factor beta1 activity in triggering lung fibrosis</article-title>. <source>ACS Nano</source> (<year>2017</year>) <volume>11</volume>:<fpage>1659</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.6b07461</pub-id><?supplied-pmid 28085241?><pub-id pub-id-type="pmid">28085241</pub-id></mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mi</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>HZ</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>JP</given-names></name><name><surname>Ma</surname><given-names>YG</given-names></name><etal/></person-group>. <article-title>Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms</article-title>. <source>J Immunol.</source> (<year>2011</year>) <volume>187</volume>:<fpage>3003</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1004081</pub-id><?supplied-pmid 21841134?><pub-id pub-id-type="pmid">21841134</pub-id></mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Dai</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Gu</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name></person-group>. <article-title>Blocking the Wnt/beta-catenin pathway by lentivirus-mediated short hairpin RNA targeting beta-catenin gene suppresses silica-induced lung fibrosis in mice</article-title>. <source>Int J Environ Res Public Health</source> (<year>2015</year>) <volume>12</volume>:<fpage>10739</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.3390/ijerph120910739</pub-id><?supplied-pmid 26340635?><pub-id pub-id-type="pmid">26340635</pub-id></mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rong</surname><given-names>Y</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Cui</surname><given-names>X</given-names></name><name><surname>Xiao</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Blocking TGF-beta expression inhibits silica particle-induced epithelial-mesenchymal transition in human lung epithelial cells</article-title>. <source>Environ Toxicol Pharmacol.</source> (<year>2015</year>) <volume>40</volume>:<fpage>861</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.etap.2015.09.014</pub-id><?supplied-pmid 26476888?><pub-id pub-id-type="pmid">26476888</pub-id></mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neuzillet</surname><given-names>C</given-names></name><name><surname>Tijeras-Raballand</surname><given-names>A</given-names></name><name><surname>Cohen</surname><given-names>R</given-names></name><name><surname>Cros</surname><given-names>J</given-names></name><name><surname>Faivre</surname><given-names>S</given-names></name><name><surname>Raymond</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Targeting the TGFbeta pathway for cancer therapy</article-title>. <source>Pharmacol Ther.</source> (<year>2015</year>) <volume>147</volume>:<fpage>22</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2014.11.001</pub-id><?supplied-pmid 25444759?><pub-id pub-id-type="pmid">25444759</pub-id></mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shull</surname><given-names>MM</given-names></name><name><surname>Ormsby</surname><given-names>I</given-names></name><name><surname>Kier</surname><given-names>AB</given-names></name><name><surname>Pawlowski</surname><given-names>S</given-names></name><name><surname>Diebold</surname><given-names>RJ</given-names></name><name><surname>Yin</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease</article-title>. <source>Nature</source> (<year>1992</year>) <volume>359</volume>:<fpage>693</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/359693a0</pub-id><?supplied-pmid 1436033?><pub-id pub-id-type="pmid">1436033</pub-id></mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Driscoll</surname><given-names>KE</given-names></name><name><surname>Carter</surname><given-names>JM</given-names></name><name><surname>Howard</surname><given-names>BW</given-names></name><name><surname>Hassenbein</surname><given-names>D</given-names></name><name><surname>Burdick</surname><given-names>M</given-names></name><name><surname>Kunkel</surname><given-names>SL</given-names></name><etal/></person-group>. <article-title>Interleukin-10 regulates quartz-induced pulmonary inflammation in rats</article-title>. <source>Am J Physiol.</source> (<year>1998</year>) <volume>275</volume>(<fpage>5 Pt 1</fpage>):<fpage>L887</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1152/ajplung.1998.275.5.L887</pub-id><?supplied-pmid 9815105?><pub-id pub-id-type="pmid">9815105</pub-id></mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hara</surname><given-names>K</given-names></name><name><surname>Shirasuna</surname><given-names>K</given-names></name><name><surname>Usui</surname><given-names>F</given-names></name><name><surname>Karasawa</surname><given-names>T</given-names></name><name><surname>Mizushina</surname><given-names>Y</given-names></name><name><surname>Kimura</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Interferon-tau attenuates uptake of nanoparticles and secretion of interleukin-1beta in macrophages</article-title>. <source>PLoS ONE</source> (<year>2014</year>) <volume>9</volume>:<fpage>e113974</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0113974</pub-id><?supplied-pmid 25486008?><pub-id pub-id-type="pmid">25486008</pub-id></mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Coradin</surname><given-names>T</given-names></name><name><surname>Helary</surname><given-names>C</given-names></name></person-group>. <article-title>Modulating inflammation in a cutaneous chronic wound model by IL-10 released from collagen-silica nanocomposites via gene delivery</article-title>. <source>Biomater Sci.</source> (<year>2018</year>) <volume>6</volume>:<fpage>398</fpage>&#x02013;<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1039/c7bm01024a</pub-id><?supplied-pmid 29337327?><pub-id pub-id-type="pmid">29337327</pub-id></mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>C</given-names></name><name><surname>Fireman</surname><given-names>E</given-names></name><name><surname>Ganor</surname><given-names>E</given-names></name><name><surname>Man</surname><given-names>A</given-names></name><name><surname>Ribak</surname><given-names>J</given-names></name><name><surname>Lerman</surname><given-names>Y</given-names></name></person-group>. <article-title>Accelerated silicosis with mixed-dust pneumoconiosis in a hard-metal grinder</article-title>. <source>J Occup Environ Med.</source> (<year>1999</year>) <volume>41</volume>:<fpage>480</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1097/00043764-199906000-00014</pub-id><?supplied-pmid 10390699?><pub-id pub-id-type="pmid">10390699</pub-id></mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chene</surname><given-names>AL</given-names></name><name><surname>d'Almeida</surname><given-names>S</given-names></name><name><surname>Blondy</surname><given-names>T</given-names></name><name><surname>Tabiasco</surname><given-names>J</given-names></name><name><surname>Deshayes</surname><given-names>S</given-names></name><name><surname>Fonteneau</surname><given-names>JF</given-names></name><etal/></person-group>. <article-title>Pleural effusions from patients with mesothelioma induce recruitment of monocytes and their differentiation into M2 macrophages</article-title>. <source>J Thorac Oncol.</source> (<year>2016</year>) <volume>11</volume>:<fpage>1765</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/j.jtho.2016.06.022</pub-id><?supplied-pmid 27418105?><pub-id pub-id-type="pmid">27418105</pub-id></mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackaman</surname><given-names>C</given-names></name><name><surname>Yeoh</surname><given-names>TL</given-names></name><name><surname>Acuil</surname><given-names>ML</given-names></name><name><surname>Gardner</surname><given-names>JK</given-names></name><name><surname>Nelson</surname><given-names>DJ</given-names></name></person-group>. <article-title>Murine mesothelioma induces locally-proliferating IL-10<sup>+</sup>TNF-alpha<sup>+</sup>CD206<sup>&#x02212;</sup>CX3CR1<sup>+</sup> M3 macrophages that can be selectively depleted by chemotherapy or immunotherapy</article-title>. <source>Oncoimmunology</source> (<year>2016</year>) <volume>5</volume>:<fpage>e1173299</fpage>. <pub-id pub-id-type="doi">10.1080/2162402X.2016.1173299</pub-id><?supplied-pmid 27471652?><pub-id pub-id-type="pmid">27471652</pub-id></mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bode</surname><given-names>C</given-names></name><name><surname>Kinjo</surname><given-names>T</given-names></name><name><surname>Alvord</surname><given-names>WG</given-names></name><name><surname>Klinman</surname><given-names>DM</given-names></name></person-group>. <article-title>Suppressive oligodeoxynucleotides reduce lung cancer susceptibility in mice with silicosis</article-title>. <source>Carcinogenesis</source> (<year>2014</year>) <volume>35</volume>:<fpage>1078</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1093/carcin/bgu005</pub-id><?supplied-pmid 24403310?><pub-id pub-id-type="pmid">24403310</pub-id></mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huaux</surname><given-names>F</given-names></name><name><surname>Arras</surname><given-names>M</given-names></name><name><surname>Vink</surname><given-names>A</given-names></name><name><surname>Renauld</surname><given-names>JC</given-names></name><name><surname>Lison</surname><given-names>D</given-names></name></person-group>. <article-title>Soluble tumor necrosis factor (TNF) receptors p55 and p75 and interleukin-10 downregulate TNF-alpha activity during the lung response to silica particles in NMRI mice</article-title>. <source>Am J Respir Cell Mol Biol.</source> (<year>1999</year>) <volume>21</volume>:<fpage>137</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1165/ajrcmb.21.1.3570</pub-id><?supplied-pmid 10385602?><pub-id pub-id-type="pmid">10385602</pub-id></mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>CG</given-names></name><name><surname>Homer</surname><given-names>RJ</given-names></name><name><surname>Cohn</surname><given-names>L</given-names></name><name><surname>Link</surname><given-names>H</given-names></name><name><surname>Jung</surname><given-names>S</given-names></name><name><surname>Craft</surname><given-names>JE</given-names></name><etal/></person-group>. <article-title>Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways</article-title>. <source>J Biol Chem.</source> (<year>2002</year>) <volume>277</volume>:<fpage>35466</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M206395200</pub-id><?supplied-pmid 12107190?><pub-id pub-id-type="pmid">12107190</pub-id></mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Louie</surname><given-names>MC</given-names></name><name><surname>Vannella</surname><given-names>KM</given-names></name><name><surname>Wilke</surname><given-names>CA</given-names></name><name><surname>LeVine</surname><given-names>AM</given-names></name><name><surname>Moore</surname><given-names>BB</given-names></name><etal/></person-group>. <article-title>New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis</article-title>. <source>Am J Physiol Lung Cell Mol Physiol.</source> (<year>2011</year>) <volume>300</volume>:<fpage>L341</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1152/ajplung.00122.2010</pub-id><?supplied-pmid 21131395?><pub-id pub-id-type="pmid">21131395</pub-id></mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbarin</surname><given-names>V</given-names></name><name><surname>Arras</surname><given-names>M</given-names></name><name><surname>Misson</surname><given-names>P</given-names></name><name><surname>Delos</surname><given-names>M</given-names></name><name><surname>McGarry</surname><given-names>B</given-names></name><name><surname>Phan</surname><given-names>SH</given-names></name><etal/></person-group>. <article-title>Characterization of the effect of interleukin-10 on silica-induced lung fibrosis in mice</article-title>. <source>Am J Respir Cell Mol Biol.</source> (<year>2004</year>) <volume>31</volume>:<fpage>78</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1165/rcmb.2003-0299OC</pub-id><?supplied-pmid 14975940?><pub-id pub-id-type="pmid">14975940</pub-id></mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbarin</surname><given-names>V</given-names></name><name><surname>Xing</surname><given-names>Z</given-names></name><name><surname>Delos</surname><given-names>M</given-names></name><name><surname>Lison</surname><given-names>D</given-names></name><name><surname>Huaux</surname><given-names>F</given-names></name></person-group>. <article-title>Pulmonary overexpression of IL-10 augments lung fibrosis and Th2 responses induced by silica particles</article-title>. <source>Am J Physiol Lung Cell Mol Physiol.</source> (<year>2005</year>) <volume>288</volume>:<fpage>L841</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1152/ajplung.00329.2004</pub-id><?supplied-pmid 15608148?><pub-id pub-id-type="pmid">15608148</pub-id></mixed-citation></ref><ref id="B93"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balaji</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>King</surname><given-names>A</given-names></name><name><surname>Le</surname><given-names>LD</given-names></name><name><surname>Bhattacharya</surname><given-names>SS</given-names></name><name><surname>Moles</surname><given-names>CM</given-names></name><etal/></person-group>. <article-title>Interleukin-10-mediated regenerative postnatal tissue repair is dependent on regulation of hyaluronan metabolism via fibroblast-specific STAT3 signaling</article-title>. <source>FASEB J.</source> (<year>2017</year>) <volume>31</volume>:<fpage>868</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1096/fj.201600856R</pub-id><?supplied-pmid 27903619?><pub-id pub-id-type="pmid">27903619</pub-id></mixed-citation></ref><ref id="B94"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miura</surname><given-names>Y</given-names></name><name><surname>Nishimura</surname><given-names>Y</given-names></name><name><surname>Katsuyama</surname><given-names>H</given-names></name><name><surname>Maeda</surname><given-names>M</given-names></name><name><surname>Hayashi</surname><given-names>H</given-names></name><name><surname>Dong</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Involvement of IL-10 and Bcl-2 in resistance against an asbestos-induced apoptosis of T cells</article-title>. <source>Apoptosis</source> (<year>2006</year>) <volume>11</volume>:<fpage>1825</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1007/s10495-006-9235-4</pub-id><?supplied-pmid 16850164?><pub-id pub-id-type="pmid">16850164</pub-id></mixed-citation></ref><ref id="B95"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maeda</surname><given-names>M</given-names></name><name><surname>Miura</surname><given-names>Y</given-names></name><name><surname>Nishimura</surname><given-names>Y</given-names></name><name><surname>Murakami</surname><given-names>S</given-names></name><name><surname>Hayashi</surname><given-names>H</given-names></name><name><surname>Kumagai</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Immunological changes in mesothelioma patients and their experimental detection</article-title>. <source>Clin Med Circ Respirat Pulm Med.</source> (<year>2008</year>) <volume>2</volume>:<fpage>11</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.4137/ccrpm.s577</pub-id><?supplied-pmid 21157517?><pub-id pub-id-type="pmid">21157517</pub-id></mixed-citation></ref><ref id="B96"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shitara</surname><given-names>K</given-names></name><name><surname>Nishikawa</surname><given-names>H</given-names></name></person-group>. <article-title>Regulatory T cells: a potential target in cancer immunotherapy</article-title>. <source>Ann N Y Acad Sci.</source> (<year>2018</year>) <volume>1417</volume>:<fpage>104</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1111/nyas.13625</pub-id><?supplied-pmid 29566262?><pub-id pub-id-type="pmid">29566262</pub-id></mixed-citation></ref><ref id="B97"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Du</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Blockade of Wnt/beta-catenin pathway aggravated silica-induced lung inflammation through tregs regulation on Th immune responses</article-title>. <source>Mediators Inflamm.</source> (<year>2016</year>) <volume>2016</volume>:<fpage>6235614</fpage>. <pub-id pub-id-type="doi">10.1155/2016/6235614</pub-id><?supplied-pmid 27069316?><pub-id pub-id-type="pmid">27069316</pub-id></mixed-citation></ref><ref id="B98"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohamud</surname><given-names>R</given-names></name><name><surname>LeMasurier</surname><given-names>JS</given-names></name><name><surname>Boer</surname><given-names>JC</given-names></name><name><surname>Sieow</surname><given-names>JL</given-names></name><name><surname>Rolland</surname><given-names>JM</given-names></name><name><surname>O'Hehir</surname><given-names>RE</given-names></name><etal/></person-group>. <article-title>Synthetic nanoparticles that promote tumor necrosis factor receptor 2 expressing regulatory T cells in the lung and resistance to allergic airways inflammation</article-title>. <source>Front Immunol.</source> (<year>2017</year>) <volume>8</volume>:<fpage>1812</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.01812</pub-id><?supplied-pmid 29312323?><pub-id pub-id-type="pmid">29312323</pub-id></mixed-citation></ref><ref id="B99"><label>99.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freire</surname><given-names>J</given-names></name><name><surname>Ajona</surname><given-names>D</given-names></name><name><surname>de Biurrun</surname><given-names>G</given-names></name><name><surname>Agorreta</surname><given-names>J</given-names></name><name><surname>Segura</surname><given-names>V</given-names></name><name><surname>Guruceaga</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Silica-induced chronic inflammation promotes lung carcinogenesis in the context of an immunosuppressive microenvironment</article-title>. <source>Neoplasia</source> (<year>2013</year>) <volume>15</volume>:<fpage>913</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1593/neo.13310</pub-id><?supplied-pmid 23908592?><pub-id pub-id-type="pmid">23908592</pub-id></mixed-citation></ref><ref id="B100"><label>100.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornelissen</surname><given-names>R</given-names></name><name><surname>Hegmans</surname><given-names>JP</given-names></name><name><surname>Maat</surname><given-names>AP</given-names></name><name><surname>Kaijen-Lambers</surname><given-names>ME</given-names></name><name><surname>Bezemer</surname><given-names>K</given-names></name><name><surname>Hendriks</surname><given-names>RW</given-names></name><etal/></person-group>. <article-title>Extended tumor control after dendritic cell vaccination with low-dose cyclophosphamide as adjuvant treatment in patients with malignant pleural mesothelioma</article-title>. <source>Am J Respir Crit Care Med.</source> (<year>2016</year>) <volume>193</volume>:<fpage>1023</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.201508-1573OC</pub-id><?supplied-pmid 26652184?><pub-id pub-id-type="pmid">26652184</pub-id></mixed-citation></ref><ref id="B101"><label>101.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Dai</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Weng</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Role of IL-10-producing regulatory B cells in modulating T-helper cell immune responses during silica-induced lung inflammation and fibrosis</article-title>. <source>Sci Rep.</source> (<year>2016</year>) <volume>6</volume>:<fpage>28911</fpage>. <pub-id pub-id-type="doi">10.1038/srep28911</pub-id><?supplied-pmid 27354007?><pub-id pub-id-type="pmid">27354007</pub-id></mixed-citation></ref><ref id="B102"><label>102.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosser</surname><given-names>EC</given-names></name><name><surname>Mauri</surname><given-names>C</given-names></name></person-group>. <article-title>Regulatory B cells: origin, phenotype, and function</article-title>. <source>Immunity</source> (<year>2015</year>) <volume>42</volume>:<fpage>607</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2015.04.005</pub-id><?supplied-pmid 25902480?><pub-id pub-id-type="pmid">25902480</pub-id></mixed-citation></ref><ref id="B103"><label>103.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarvaria</surname><given-names>A</given-names></name><name><surname>Madrigal</surname><given-names>JA</given-names></name><name><surname>Saudemont</surname><given-names>A</given-names></name></person-group>. <article-title>B cell regulation in cancer and anti-tumor immunity</article-title>. <source>Cell Mol Immunol.</source> (<year>2017</year>) <volume>14</volume>:<fpage>662</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1038/cmi.2017.35</pub-id><?supplied-pmid 28626234?><pub-id pub-id-type="pmid">28626234</pub-id></mixed-citation></ref><ref id="B104"><label>104.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Weng</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group>. <article-title>IL-10-producing B cells suppress effector T cells activation and promote regulatory T cells in crystalline silica-induced inflammatory response <italic>in vitro</italic></article-title>. <source>Mediators Inflamm.</source> (<year>2017</year>) <volume>2017</volume>:<fpage>8415094</fpage>. <pub-id pub-id-type="doi">10.1155/2017/8415094</pub-id><?supplied-pmid 28831210?><pub-id pub-id-type="pmid">28831210</pub-id></mixed-citation></ref><ref id="B105"><label>105.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saradna</surname><given-names>A</given-names></name><name><surname>Do</surname><given-names>DC</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Fu</surname><given-names>QL</given-names></name><name><surname>Gao</surname><given-names>P</given-names></name></person-group>. <article-title>Macrophage polarization and allergic asthma</article-title>. <source>Transl Res.</source> (<year>2018</year>) <volume>191</volume>:<fpage>1</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.trsl.2017.09.002</pub-id><?supplied-pmid 29066321?><pub-id pub-id-type="pmid">29066321</pub-id></mixed-citation></ref><ref id="B106"><label>106.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujimura</surname><given-names>T</given-names></name><name><surname>Kambayashi</surname><given-names>Y</given-names></name><name><surname>Fujisawa</surname><given-names>Y</given-names></name><name><surname>Hidaka</surname><given-names>T</given-names></name><name><surname>Aiba</surname><given-names>S</given-names></name></person-group>. <article-title>Tumor-associated macrophages: therapeutic targets for skin cancer</article-title>. <source>Front Oncol.</source> (<year>2018</year>) <volume>8</volume>:<fpage>3</fpage>. <pub-id pub-id-type="doi">10.3389/fonc.2018.00003</pub-id><?supplied-pmid 29410946?><pub-id pub-id-type="pmid">29410946</pub-id></mixed-citation></ref><ref id="B107"><label>107.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>M</given-names></name><name><surname>Cho</surname><given-names>WS</given-names></name><name><surname>Han</surname><given-names>BS</given-names></name><name><surname>Cho</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Yi</surname><given-names>JY</given-names></name><etal/></person-group>. <article-title>Transient pulmonary fibrogenic effect induced by intratracheal instillation of ultrafine amorphous silica in A/J mice</article-title>. <source>Toxicol Lett.</source> (<year>2008</year>) <volume>182</volume>:<fpage>97</fpage>&#x02013;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxlet.2008.08.019</pub-id><?supplied-pmid 18835341?><pub-id pub-id-type="pmid">18835341</pub-id></mixed-citation></ref><ref id="B108"><label>108.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Misson</surname><given-names>P</given-names></name><name><surname>van den Brule</surname><given-names>S</given-names></name><name><surname>Barbarin</surname><given-names>V</given-names></name><name><surname>Lison</surname><given-names>D</given-names></name><name><surname>Huaux</surname><given-names>F</given-names></name></person-group>. <article-title>Markers of macrophage differentiation in experimental silicosis</article-title>. <source>J Leukoc Biol.</source> (<year>2004</year>) <volume>76</volume>:<fpage>926</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.0104019</pub-id><?supplied-pmid 15292275?><pub-id pub-id-type="pmid">15292275</pub-id></mixed-citation></ref><ref id="B109"><label>109.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Meena</surname><given-names>R</given-names></name><name><surname>Paulraj</surname><given-names>R</given-names></name></person-group>. <article-title>Role of macrophage (M1 and M2) in titanium-dioxide nanoparticle-induced oxidative stress and inflammatory response in rat</article-title>. <source>Appl Biochem Biotechnol.</source> (<year>2016</year>) <volume>180</volume>:<fpage>1257</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1007/s12010-016-2165-x</pub-id><?supplied-pmid 27318710?><pub-id pub-id-type="pmid">27318710</pub-id></mixed-citation></ref><ref id="B110"><label>110.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname><given-names>F</given-names></name><name><surname>Shah</surname><given-names>D</given-names></name><name><surname>Duong</surname><given-names>M</given-names></name><name><surname>Penn</surname><given-names>RB</given-names></name><name><surname>Fessler</surname><given-names>MB</given-names></name><name><surname>Madenspacher</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>A pneumocyte-macrophage paracrine lipid axis drives the lung toward fibrosis</article-title>. <source>Am J Respir Cell Mol Biol.</source> (<year>2015</year>) <volume>53</volume>:<fpage>74</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1165/rcmb.2014-0343OC</pub-id><?supplied-pmid 25409201?><pub-id pub-id-type="pmid">25409201</pub-id></mixed-citation></ref><ref id="B111"><label>111.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Migliaccio</surname><given-names>CT</given-names></name><name><surname>Buford</surname><given-names>MC</given-names></name><name><surname>Jessop</surname><given-names>F</given-names></name><name><surname>Holian</surname><given-names>A</given-names></name></person-group>. <article-title>The IL-4Ralpha pathway in macrophages and its potential role in silica-induced pulmonary fibrosis</article-title>. <source>J Leukoc Biol.</source> (<year>2008</year>) <volume>83</volume>:<fpage>630</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.0807533</pub-id><?supplied-pmid 18056481?><pub-id pub-id-type="pmid">18056481</pub-id></mixed-citation></ref><ref id="B112"><label>112.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>TP</given-names></name><name><surname>de Arantes</surname><given-names>AC</given-names></name><name><surname>do Nascimento</surname><given-names>CV</given-names></name><name><surname>Olsen</surname><given-names>PC</given-names></name><name><surname>Trentin</surname><given-names>PG</given-names></name><name><surname>Rocco</surname><given-names>PR</given-names></name><etal/></person-group>. <article-title>IL-13 immunotoxin accelerates resolution of lung pathological changes triggered by silica particles in mice</article-title>. <source>J Immunol.</source> (<year>2013</year>) <volume>191</volume>:<fpage>5220</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1203551</pub-id><?supplied-pmid 24133168?><pub-id pub-id-type="pmid">24133168</pub-id></mixed-citation></ref><ref id="B113"><label>113.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tcyganov</surname><given-names>E</given-names></name><name><surname>Mastio</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>E</given-names></name><name><surname>Gabrilovich</surname><given-names>DI</given-names></name></person-group>. <article-title>Plasticity of myeloid-derived suppressor cells in cancer</article-title>. <source>Curr Opin Immunol.</source> (<year>2018</year>) <volume>51</volume>:<fpage>76</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.coi.2018.03.009</pub-id><?supplied-pmid 29547768?><pub-id pub-id-type="pmid">29547768</pub-id></mixed-citation></ref><ref id="B114"><label>114.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veltman</surname><given-names>JD</given-names></name><name><surname>Lambers</surname><given-names>ME</given-names></name><name><surname>van Nimwegen</surname><given-names>M</given-names></name><name><surname>Hendriks</surname><given-names>RW</given-names></name><name><surname>Hoogsteden</surname><given-names>HC</given-names></name><name><surname>Aerts</surname><given-names>JG</given-names></name><etal/></person-group>. <article-title>COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function</article-title>. <source>BMC Cancer</source> (<year>2010</year>) <volume>10</volume>:<fpage>464</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2407-10-464</pub-id><?supplied-pmid 20804550?><pub-id pub-id-type="pmid">20804550</pub-id></mixed-citation></ref><ref id="B115"><label>115.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boraschi</surname><given-names>D</given-names></name><name><surname>Italiani</surname><given-names>P</given-names></name><name><surname>Palomba</surname><given-names>R</given-names></name><name><surname>Decuzzi</surname><given-names>P</given-names></name><name><surname>Duschl</surname><given-names>A</given-names></name><name><surname>Fadeel</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Nanoparticles and innate immunity: new perspectives on host defence</article-title>. <source>Semin Immunol.</source> (<year>2017</year>) <volume>34</volume>:<fpage>33</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.smim.2017.08.013</pub-id><?supplied-pmid 28869063?><pub-id pub-id-type="pmid">28869063</pub-id></mixed-citation></ref><ref id="B116"><label>116.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chauhan</surname><given-names>AS</given-names></name><name><surname>Diwan</surname><given-names>PV</given-names></name><name><surname>Jain</surname><given-names>NK</given-names></name><name><surname>Tomalia</surname><given-names>DA</given-names></name></person-group>. <article-title>Unexpected <italic>in vivo</italic> anti-inflammatory activity observed for simple, surface functionalized poly(amidoamine) dendrimers</article-title>. <source>Biomacromolecules</source> (<year>2009</year>) <volume>10</volume>:<fpage>1195</fpage>&#x02013;<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1021/bm9000298</pub-id><?supplied-pmid 19348417?><pub-id pub-id-type="pmid">19348417</pub-id></mixed-citation></ref><ref id="B117"><label>117.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajan</surname><given-names>R</given-names></name><name><surname>Sabnani</surname><given-names>MK</given-names></name><name><surname>Mavinkurve</surname><given-names>V</given-names></name><name><surname>Shmeeda</surname><given-names>H</given-names></name><name><surname>Mansouri</surname><given-names>H</given-names></name><name><surname>Bonkoungou</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Liposome-induced immunosuppression and tumor growth is mediated by macrophages and mitigated by liposome-encapsulated alendronate</article-title>. <source>J Control Release</source> (<year>2018</year>) <volume>271</volume>:<fpage>139</fpage>&#x02013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.jconrel.2017.12.023</pub-id><?supplied-pmid 29277680?><pub-id pub-id-type="pmid">29277680</pub-id></mixed-citation></ref><ref id="B118"><label>118.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumbayev</surname><given-names>VV</given-names></name><name><surname>Yasinska</surname><given-names>IM</given-names></name><name><surname>Garcia</surname><given-names>CP</given-names></name><name><surname>Gilliland</surname><given-names>D</given-names></name><name><surname>Lall</surname><given-names>GS</given-names></name><name><surname>Gibbs</surname><given-names>BF</given-names></name><etal/></person-group>. <article-title>Gold nanoparticles downregulate interleukin-1beta-induced pro-inflammatory responses</article-title>. <source>Small</source> (<year>2013</year>) <volume>9</volume>:<fpage>472</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1002/smll.201201528</pub-id><?supplied-pmid 23112137?><pub-id pub-id-type="pmid">23112137</pub-id></mixed-citation></ref><ref id="B119"><label>119.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>WJ</given-names></name><name><surname>Kim</surname><given-names>JJ</given-names></name><name><surname>Kim</surname><given-names>TJ</given-names></name><name><surname>Ye</surname><given-names>SK</given-names></name><name><surname>Song</surname><given-names>MD</given-names></name><etal/></person-group>. <article-title>Gold nanoparticles attenuate LPS-induced NO production through the inhibition of NF-kappaB and IFN-beta/STAT1 pathways in RAW264</article-title>.7 cells. <source>Nitric Oxide</source> (<year>2010</year>) <volume>23</volume>:<fpage>214</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.niox.2010.06.005</pub-id><?supplied-pmid 20547236?><pub-id pub-id-type="pmid">20547236</pub-id></mixed-citation></ref><ref id="B120"><label>120.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>HY</given-names></name><name><surname>Chung</surname><given-names>MC</given-names></name><name><surname>Wang</surname><given-names>CC</given-names></name><name><surname>Huang</surname><given-names>CH</given-names></name><name><surname>Liang</surname><given-names>HJ</given-names></name><name><surname>Jan</surname><given-names>TR</given-names></name></person-group>. <article-title>Iron oxide nanoparticles suppress the production of IL-1beta via the secretory lysosomal pathway in murine microglial cells</article-title>. <source>Part Fibre Toxicol.</source> (<year>2013</year>) <volume>10</volume>:<fpage>46</fpage>. <pub-id pub-id-type="doi">10.1186/1743-8977-10-46</pub-id><?supplied-pmid 24047432?><pub-id pub-id-type="pmid">24047432</pub-id></mixed-citation></ref><ref id="B121"><label>121.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SS</given-names></name><name><surname>Song</surname><given-names>W</given-names></name><name><surname>Cho</surname><given-names>M</given-names></name><name><surname>Puppala</surname><given-names>HL</given-names></name><name><surname>Nguyen</surname><given-names>P</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Antioxidant properties of cerium oxide nanocrystals as a function of nanocrystal diameter and surface coating</article-title>. <source>ACS Nano</source> (<year>2013</year>) <volume>7</volume>:<fpage>9693</fpage>&#x02013;<lpage>703</lpage>. <pub-id pub-id-type="doi">10.1021/nn4026806</pub-id><?supplied-pmid 24079896?><pub-id pub-id-type="pmid">24079896</pub-id></mixed-citation></ref><ref id="B122"><label>122.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gharbi</surname><given-names>N</given-names></name><name><surname>Pressac</surname><given-names>M</given-names></name><name><surname>Hadchouel</surname><given-names>M</given-names></name><name><surname>Szwarc</surname><given-names>H</given-names></name><name><surname>Wilson</surname><given-names>SR</given-names></name><name><surname>Moussa</surname><given-names>F</given-names></name></person-group>. <article-title>[60]fullerene is a powerful antioxidant <italic>in vivo</italic> with no acute or subacute toxicity</article-title>. <source>Nano Lett.</source> (<year>2005</year>) <volume>5</volume>:<fpage>2578</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1021/nl051866b</pub-id><?supplied-pmid 16351219?><pub-id pub-id-type="pmid">16351219</pub-id></mixed-citation></ref><ref id="B123"><label>123.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamashita</surname><given-names>K</given-names></name><name><surname>Sakai</surname><given-names>M</given-names></name><name><surname>Takemoto</surname><given-names>N</given-names></name><name><surname>Tsukimoto</surname><given-names>M</given-names></name><name><surname>Uchida</surname><given-names>K</given-names></name><name><surname>Yajima</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Attenuation of delayed-type hypersensitivity by fullerene treatment</article-title>. <source>Toxicology</source> (<year>2009</year>) <volume>261</volume>:<fpage>19</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.tox.2009.04.034</pub-id><?supplied-pmid 19376187?><pub-id pub-id-type="pmid">19376187</pub-id></mixed-citation></ref><ref id="B124"><label>124.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomic</surname><given-names>S</given-names></name><name><surname>Janjetovic</surname><given-names>K</given-names></name><name><surname>Mihajlovic</surname><given-names>D</given-names></name><name><surname>Milenkovic</surname><given-names>M</given-names></name><name><surname>Kravic-Stevovic</surname><given-names>T</given-names></name><name><surname>Markovic</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Graphene quantum dots suppress proinflammatory T cell responses via autophagy-dependent induction of tolerogenic dendritic cells</article-title>. <source>Biomaterials</source> (<year>2017</year>) <volume>146</volume>:<fpage>13</fpage>&#x02013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2017.08.040</pub-id><?supplied-pmid 28892752?><pub-id pub-id-type="pmid">28892752</pub-id></mixed-citation></ref><ref id="B125"><label>125.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blank</surname><given-names>F</given-names></name><name><surname>Gerber</surname><given-names>P</given-names></name><name><surname>Rothen-Rutishauser</surname><given-names>B</given-names></name><name><surname>Sakulkhu</surname><given-names>U</given-names></name><name><surname>Salaklang</surname><given-names>J</given-names></name><name><surname>De Peyer</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Biomedical nanoparticles modulate specific CD4<sup>+</sup> T cell stimulation by inhibition of antigen processing in dendritic cells</article-title>. <source>Nanotoxicology</source> (<year>2011</year>) <volume>5</volume>:<fpage>606</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.3109/17435390.2010.541293</pub-id><?supplied-pmid 21231795?><pub-id pub-id-type="pmid">21231795</pub-id></mixed-citation></ref><ref id="B126"><label>126.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tkach</surname><given-names>AV</given-names></name><name><surname>Shurin</surname><given-names>GV</given-names></name><name><surname>Shurin</surname><given-names>MR</given-names></name><name><surname>Kisin</surname><given-names>ER</given-names></name><name><surname>Murray</surname><given-names>AR</given-names></name><name><surname>Young</surname><given-names>SH</given-names></name><etal/></person-group>. <article-title>Direct effects of carbon nanotubes on dendritic cells induce immune suppression upon pulmonary exposure</article-title>. <source>ACS Nano</source> (<year>2011</year>) <volume>5</volume>:<fpage>5755</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1021/nn2014479</pub-id><?supplied-pmid 21657201?><pub-id pub-id-type="pmid">21657201</pub-id></mixed-citation></ref><ref id="B127"><label>127.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>A</given-names></name><name><surname>Stueckle</surname><given-names>TA</given-names></name><name><surname>Mercer</surname><given-names>RR</given-names></name><name><surname>Derk</surname><given-names>R</given-names></name><name><surname>Rojanasakul</surname><given-names>Y</given-names></name><name><surname>Castranova</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Identification of TGF-beta receptor-1 as a key regulator of carbon nanotube-induced fibrogenesis</article-title>. <source>Am J Physiol Lung Cell Mol Physiol.</source> (<year>2015</year>) <volume>309</volume>:<fpage>L821</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1152/ajplung.00002.2015</pub-id><?supplied-pmid 26472812?><pub-id pub-id-type="pmid">26472812</pub-id></mixed-citation></ref><ref id="B128"><label>128.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Bishoff</surname><given-names>B</given-names></name><name><surname>Mercer</surname><given-names>RR</given-names></name><name><surname>Barger</surname><given-names>M</given-names></name><name><surname>Schwegler-Berry</surname><given-names>D</given-names></name><name><surname>Castranova</surname><given-names>V</given-names></name></person-group>. <article-title>Role of epithelial-mesenchymal transition (EMT) and fibroblast function in cerium oxide nanoparticles-induced lung fibrosis</article-title>. <source>Toxicol Appl Pharmacol.</source> (<year>2017</year>) <volume>323</volume>:<fpage>16</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/j.taap.2017.03.015</pub-id><?supplied-pmid 28315692?><pub-id pub-id-type="pmid">28315692</pub-id></mixed-citation></ref><ref id="B129"><label>129.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moon</surname><given-names>EY</given-names></name><name><surname>Yi</surname><given-names>GH</given-names></name><name><surname>Kang</surname><given-names>JS</given-names></name><name><surname>Lim</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>HM</given-names></name><name><surname>Pyo</surname><given-names>S</given-names></name></person-group>. <article-title>An increase in mouse tumor growth by an <italic>in vivo</italic> immunomodulating effect of titanium dioxide nanoparticles</article-title>. <source>J Immunotoxicol.</source> (<year>2011</year>) <volume>8</volume>:<fpage>56</fpage>&#x02013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.3109/1547691X.2010.543995</pub-id><?supplied-pmid 21288165?><pub-id pub-id-type="pmid">21288165</pub-id></mixed-citation></ref><ref id="B130"><label>130.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanpui</surname><given-names>P</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Loeb</surname><given-names>JC</given-names></name><name><surname>Bisesi</surname><given-names>JH</given-names><suffix>Jr</suffix></name><name><surname>Khan</surname><given-names>IA</given-names></name><name><surname>Afrooz</surname><given-names>AR</given-names></name><etal/></person-group>. <article-title>Single-walled carbon nanotubes increase pandemic influenza A H1N1 virus infectivity of lung epithelial cells</article-title>. <source>Part Fibre Toxicol.</source> (<year>2014</year>) <volume>11</volume>:<fpage>66</fpage>. <pub-id pub-id-type="doi">10.1186/s12989-014-0066-0</pub-id><?supplied-pmid 25497303?><pub-id pub-id-type="pmid">25497303</pub-id></mixed-citation></ref><ref id="B131"><label>131.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Findlay</surname><given-names>F</given-names></name><name><surname>Pohl</surname><given-names>J</given-names></name><name><surname>Svoboda</surname><given-names>P</given-names></name><name><surname>Shakamuri</surname><given-names>P</given-names></name><name><surname>McLean</surname><given-names>K</given-names></name><name><surname>Inglis</surname><given-names>NF</given-names></name><etal/></person-group>. <article-title>Carbon nanoparticles inhibit the antimicrobial activities of the human cathelicidin LL-37 through structural alteration</article-title>. <source>J Immunol.</source> (<year>2017</year>) <volume>199</volume>:<fpage>2483</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1700706</pub-id><?supplied-pmid 28814602?><pub-id pub-id-type="pmid">28814602</pub-id></mixed-citation></ref><ref id="B132"><label>132.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanterman</surname><given-names>J</given-names></name><name><surname>Sade-Feldman</surname><given-names>M</given-names></name><name><surname>Baniyash</surname><given-names>M</given-names></name></person-group>. <article-title>New insights into chronic inflammation-induced immunosuppression</article-title>. <source>Semin Cancer Biol.</source> (<year>2012</year>) <volume>22</volume>:<fpage>307</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcancer.2012.02.008</pub-id><?supplied-pmid 22387003?><pub-id pub-id-type="pmid">22387003</pub-id></mixed-citation></ref><ref id="B133"><label>133.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocha-Parise</surname><given-names>M</given-names></name><name><surname>Santos</surname><given-names>LM</given-names></name><name><surname>Damoiseaux</surname><given-names>JG</given-names></name><name><surname>Bagatin</surname><given-names>E</given-names></name><name><surname>Lido</surname><given-names>AV</given-names></name><name><surname>Torello</surname><given-names>CO</given-names></name><etal/></person-group>. <article-title>Lymphocyte activation in silica-exposed workers</article-title>. <source>Int J Hyg Environ Health</source> (<year>2014</year>) <volume>217</volume>:<fpage>586</fpage>&#x02013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijheh.2013.11.002</pub-id><?supplied-pmid 24332681?><pub-id pub-id-type="pmid">24332681</pub-id></mixed-citation></ref><ref id="B134"><label>134.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rimal</surname><given-names>B</given-names></name><name><surname>Greenberg</surname><given-names>AK</given-names></name><name><surname>Rom</surname><given-names>WN</given-names></name></person-group>. <article-title>Basic pathogenetic mechanisms in silicosis: current understanding</article-title>. <source>Curr Opin Pulm Med.</source> (<year>2005</year>) <volume>11</volume>:<fpage>169</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1097/01.mcp.0000152998.11335.24</pub-id><?supplied-pmid 15699791?><pub-id pub-id-type="pmid">15699791</pub-id></mixed-citation></ref><ref id="B135"><label>135.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breznan</surname><given-names>D</given-names></name><name><surname>Karthikeyan</surname><given-names>S</given-names></name><name><surname>Phaneuf</surname><given-names>M</given-names></name><name><surname>Kumarathasan</surname><given-names>P</given-names></name><name><surname>Cakmak</surname><given-names>S</given-names></name><name><surname>Denison</surname><given-names>MS</given-names></name><etal/></person-group>. <article-title>Development of an integrated approach for comparison of <italic>in vitro</italic> and <italic>in vivo</italic> responses to particulate matter</article-title>. <source>Part Fibre Toxicol.</source> (<year>2016</year>) <volume>13</volume>:<fpage>41</fpage>. <pub-id pub-id-type="doi">10.1186/s12989-016-0152-6</pub-id><?supplied-pmid 27520027?><pub-id pub-id-type="pmid">27520027</pub-id></mixed-citation></ref><ref id="B136"><label>136.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasper</surname><given-names>J</given-names></name><name><surname>Hermanns</surname><given-names>MI</given-names></name><name><surname>Bantz</surname><given-names>C</given-names></name><name><surname>Maskos</surname><given-names>M</given-names></name><name><surname>Stauber</surname><given-names>R</given-names></name><name><surname>Pohl</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Inflammatory and cytotoxic responses of an alveolar-capillary coculture model to silica nanoparticles: comparison with conventional monocultures</article-title>. <source>Part Fibre Toxicol.</source> (<year>2011</year>) <volume>8</volume>:<fpage>6</fpage>. <pub-id pub-id-type="doi">10.1186/1743-8977-8-6</pub-id><?supplied-pmid 21272353?><pub-id pub-id-type="pmid">21272353</pub-id></mixed-citation></ref><ref id="B137"><label>137.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Italiani</surname><given-names>P</given-names></name><name><surname>Mazza</surname><given-names>EM</given-names></name><name><surname>Lucchesi</surname><given-names>D</given-names></name><name><surname>Cifola</surname><given-names>I</given-names></name><name><surname>Gemelli</surname><given-names>C</given-names></name><name><surname>Grande</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Transcriptomic profiling of the development of the inflammatory response in human monocytes <italic>in vitro</italic></article-title>. <source>PLoS ONE</source> (<year>2014</year>) <volume>9</volume>:<fpage>e87680</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0087680</pub-id><?supplied-pmid 24498352?><pub-id pub-id-type="pmid">24498352</pub-id></mixed-citation></ref><ref id="B138"><label>138.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamichhane</surname><given-names>P</given-names></name><name><surname>Karyampudi</surname><given-names>L</given-names></name><name><surname>Shreeder</surname><given-names>B</given-names></name><name><surname>Krempski</surname><given-names>J</given-names></name><name><surname>Bahr</surname><given-names>D</given-names></name><name><surname>Daum</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>IL10 release upon PD-1 blockade sustains immunosuppression in ovarian cancer</article-title>. <source>Cancer Res.</source> (<year>2017</year>) <volume>77</volume>:<fpage>6667</fpage>&#x02013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-17-0740</pub-id><?supplied-pmid 28993412?><pub-id pub-id-type="pmid">28993412</pub-id></mixed-citation></ref><ref id="B139"><label>139.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stockis</surname><given-names>J</given-names></name><name><surname>Lienart</surname><given-names>S</given-names></name><name><surname>Colau</surname><given-names>D</given-names></name><name><surname>Collignon</surname><given-names>A</given-names></name><name><surname>Nishimura</surname><given-names>SL</given-names></name><name><surname>Sheppard</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Blocking immunosuppression by human tregs <italic>in vivo</italic> with antibodies targeting integrin &#x003b1;V&#x003b2;8</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2017</year>) <volume>114</volume>:<fpage>E10161</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1710680114</pub-id><?supplied-pmid 29109269?><pub-id pub-id-type="pmid">29109269</pub-id></mixed-citation></ref><ref id="B140"><label>140.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>SA</given-names></name><name><surname>Minn</surname><given-names>AJ</given-names></name></person-group>. <article-title>Combination cancer therapy with immune checkpoint blockade: mechanisms and strategies</article-title>. <source>Immunity</source> (<year>2018</year>) <volume>48</volume>:<fpage>417</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2018.03.007</pub-id><?supplied-pmid 29562193?><pub-id pub-id-type="pmid">29562193</pub-id></mixed-citation></ref><ref id="B141"><label>141.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maeda</surname><given-names>M</given-names></name><name><surname>Nishimura</surname><given-names>Y</given-names></name><name><surname>Kumagai</surname><given-names>N</given-names></name><name><surname>Hayashi</surname><given-names>H</given-names></name><name><surname>Hatayama</surname><given-names>T</given-names></name><name><surname>Katoh</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Dysregulation of the immune system caused by silica and asbestos</article-title>. <source>J Immunotoxicol.</source> (<year>2010</year>) <volume>7</volume>:<fpage>268</fpage>&#x02013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.3109/1547691X.2010.512579</pub-id><?supplied-pmid 20849352?><pub-id pub-id-type="pmid">20849352</pub-id></mixed-citation></ref><ref id="B142"><label>142.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petsonk</surname><given-names>EL</given-names></name><name><surname>Rose</surname><given-names>C</given-names></name><name><surname>Cohen</surname><given-names>R</given-names></name></person-group>. <article-title>Coal mine dust lung disease. New lessons from old exposure</article-title>. <source>Am J Respir Crit Care Med.</source> (<year>2013</year>) <volume>187</volume>:<fpage>1178</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.201301-0042CI</pub-id><?supplied-pmid 23590267?><pub-id pub-id-type="pmid">23590267</pub-id></mixed-citation></ref></ref-list><glossary><def-list><title>Abbreviations</title><def-item><term>T or B regs</term><def><p>Regulatory T or B lymphocytes</p></def></def-item><def-item><term>MDSC</term><def><p>Myeloid Derived Suppressive Cells</p></def></def-item><def-item><term>M2 macrophages</term><def><p>Alternatively differentiated macrophages</p></def></def-item><def-item><term>Th</term><def><p>CD4<sup>+</sup> T helper lymphocytes</p></def></def-item><def-item><term>&#x003b3;&#x003b4; T cells</term><def><p>gamma and delta TCR chain positive T lymphocytes</p></def></def-item><def-item><term>IFN</term><def><p>Interferon</p></def></def-item><def-item><term>T eff</term><def><p>Effector T lymphocytes</p></def></def-item><def-item><term>CNT</term><def><p>Carbon nanotubes</p></def></def-item></def-list></glossary></back></article>